12 August 2024
The information contained within
this announcement is deemed by the Company to constitute inside
information as stipulated under the Market Abuse Regulations (EU)
No. 596/2014 (MAR) as in force in the United Kingdom pursuant to
the European Union (Withdrawal) Act 2018. Upon the publication of
this announcement via Regulatory Information Service (RIS), this
inside information is now considered to be in the public
domain.
WH
Ireland Group Plc
("WH
Ireland" or the "Company" and with its subsidiaries the
"Group")
Financial Results for the Twelve Months ended 31 March
2024
WH Ireland announces its final
results for the year ended 31 March 2024.
Financial &
Operating Summary
· Revenue of £21.5m (FY 2023: £26.7m)
· Underlying* loss before tax £2.5m (FY 2023: underlying loss
before tax of £2.0m)
· Statutory loss before tax £5.9m (FY 2023: loss before tax
£1.8m) reflecting impact of:
o Restructuring costs of £2.9m
(FY2023: nil)
o Reduced loss on investments
of £0.6m (FY 2023: loss of £2.7m)
o Nil benefit from other
income (FY 2023: other income of £2.2m)
· Loss
per share of 3.38p (FY 2023: loss of 3.08p)
· Cash
and cash equivalents as at 31 March 2024 of £4.9m (FY 2023:
£4.2m)
o Cash and cash equivalents of
£6.5m as at 31 July 2024
· Successful £5m placing completed in August 2023
*A reconciliation from underlying profits to statutory
profits is shown within the financial review on page
6.
The above results include the
Capital Market Division which was sold post period end on 15 July
2024
Pro-forma results
of the continuing group comprising wealth management and head
office
These pro-forma results consider what the continuing
operations results would look like following the post year end
decision to no longer actively pursue a sale of the WM business.
Refer to note 5 of the annual report for further information.
· Revenue of £11.9m (FY 2023: £14.4m)
reflecting market falls during the year
· Total AUM at £1.2bn (FY2023: £1.4bn)
· Underlying loss before tax of £0.6m (FY 2023: loss before tax
of £0.2m)
· Statutory loss before tax of £2.8m (FY 2023: loss before tax
of £1.7m)
· Loss
per share of 1.57p (175,718,098 shares)(FY 2023: loss of 2.82p, 59,172,423
shares)
Post period end
events
· Disposal of Capital Markets division completed in July 2024
for up to £5m deferred consideration
· The
disposal has resulted in reduced liabilities and a
lower working capital requirement
· Settlement of final deferred consideration relating to the
purchase of Harpsden in 2020
· Decision by the Board
to no longer actively pursue a sale of the Wealth Management
business, whilst assessing strategic opportunities if and when they
arise
Current Trading and
Outlook
· Focus on
operational development of the WM division whilst assessing
strategic opportunities
· Further reduction in
Group central costs planned following the sale of the CM
division
· These initiatives are
designed to ensure that the Group can return to sustainable
profitability
Commenting, Phillip
Wale, Chief Executive Officer said:
"The market backdrop has been extremely challenging.
While the FTSE 100 has been relatively resilient, the AIM All Share
Index fell 9% over the period. These market conditions severely
impacted transactional business (and particularly fundraisings) in
the Capital Markets Division, which, together with significant
restructuring costs, were the principal reason for the Group
reporting losses for the year.
"However, having completed the sale of the Capital
Markets division in July 2024, we have achieved a more stable
financial position for the Group against the current market
backdrop. We are now implementing plans for the growth of the
remaining WM business to return it to break even whilst finding
further efficiencies in the Group as a whole."
For further information please contact:
WH Ireland Group
plc
|
www.whirelandplc.com
|
Phillip Wale, Chief Executive Officer
|
+44(0) 20 7220 1666
|
Canaccord Genuity
Limited
|
www.canaccordgenuity.com
|
Emma Gabriel / Harry
Rees
|
+44(0) 20 3523 8000
|
MHP
Communications
|
whireland@mhpgroup.com
|
Reg Hoare / Charles Hirst
|
+44 (0) 20 7831 406117
|
Notes to
Editors:
About WH Ireland Group plc
Wealth Management Division
WH Ireland provides independent
financial planning advice and discretionary investment management.
Our goal is to build long term, mutually beneficial, working
relationships with our clients so that they can make informed &
effective choices about their money and how it can support their
lifestyle ambitions. We help clients to build a long term
financial plan and investment strategy for them and their
families.
Capital Markets
Division
The sale of the division to Zeus
Capital Limited was completed on 15 July 2024.
WH Ireland Group plc is the holding company for WH
Ireland Limited (WHI). WHI provides a high quality service across
both of its business areas - a Wealth Management (WM) division
providing investment solutions for individuals, families and
charities and a Capital Markets (CM) division which is a leading
firm for public and private companies seeking corporate advice and
investment capital.
Classification and Disclosure within Financial
Statements
During the year, the Group pursued a sale of both the
WM and CM divisions. Both sales were judged to be highly probable
at year end and so have been classified as 'held for sale' assets
within the Statement of Financial with the associated loss for the
year being shown within Discontinued Operations within the
Statement of Comprehensive Income. A breakdown of these disclosures
is shown within note 6.
Post year end, the sale of the WM business did not
proceed and the strategy for this division shifted to driving
growth in the assets under management and providing a wider level
of service to develop further revenue streams. The sale of the CM
division completed post year end in July 2024. This will assist the
group in the implementation of its plans for the growth of the
remaining WM business.
Wealth Management
WHI provides financial planning advice and
discretionary investment management. Our goal is to build
long-term, mutually beneficial, working relationships with our
clients so that they can make informed and effective choices about
their money and how it can support their lifestyle ambitions. We
help clients to build a long-term financial plan and investment
strategy for them and their families.
Capital Markets
The CM division had been specifically focused on the
public and private growth company marketplace. The team's
significant experience in this dynamic segment means that they have
been able to provide a specialist service to each of its respective
participants. For companies, we have raised public and private
growth capital, as well as provided both day-to-day and strategic
corporate advice including M&A advisory. The division's
tailored approach means that the team engages with all of the key
investor groups active in its market - High Net Worth individuals,
Family Offices, Wealth Managers and Funds. The broking, trading and
research teams provide the link between growth companies and this
broad investor base.
Chair and Chief Executive's
statement
Market backdrop
The market backdrop has been extremely
challenging. While the FTSE 100 has been relatively resilient, the
AIM All Share Index fell 9% over the period. These market
conditions severely impacted transactional business (and
particularly fundraisings) in our CM Divisions and there have been
a number of strategic issues for the board to consider.
Outlook
As shareholders will be aware the Group announced in
July 2023 that it had raised £5m through a placing of shares in the
Company. The board would like to thank shareholders for their
support for this placing which enabled stabilisation to occur in
our financial position whilst a cost reduction exercise and other
strategic initiatives were carried out.
Following a further decline in market conditions and
a persistent inflationary backdrop, the board has continued with
the strategy to actively explore opportunities and options for the
group principally a sale of all or part of its assets.
During the year a number of potential buyers
approached us in respect of a purchase of the WM division and where
it was appropriate these were actively pursued. However none of
these discussions resulted in a transaction and therefore whilst
the WM division was held as an asset for sale at the year end (and
this is reflected in the approach to the completion of the year end
accounts) it is now part of our ongoing operations and will
therefore be subject to the normal accounting treatments on an
ongoing basis in the absence of an event occurring which impacts
this assessment.
Post balance sheet date, the Group reached
completion on a deal to sell the CM division. This completed in
July 2024 and is on a deferred consideration basis. This division
was actively being marketed for sale and it was highly probable
that this sale would occur within a few months of reporting date.
This division is therefore also shown as an asset held for sale and
a discontinued operation in the subsequent Financial Statements.
The sale of this division completed in July 2024.
Looking forward
Following the sale of the CM division after the
year-end it is the intention of the Group to focus on the operation
and development of the WM division whilst assessing strategic
opportunities for the Group as they arise.
Moving forward we will further reduce costs, as
certain group and central functions can be streamlined following
the sale of the CM division. Considering this, together with the
implementation of our cost reduction programme earlier in the year,
we believe the Group Moving forward we will further reduce costs,
as certain group and central functions can be streamlined following
the sale of the CM division. Considering this, together with the
implementation of our cost reduction programme earlier in the year,
we believe the Group has an improved chance of returning the
continuing WM division to a break-even position.
The Financial Year 2024
Overall revenue fell 19.6% from the previous year
from £26.7m to £21.5m, we reduced administrative expenses by 2%
from £27.6m to £26.7m. Although our loss on investments reduced
from a £2.7m loss in the previous year to £0.6m loss, we incurred
large restructuring costs of £2.9m. These were principally
redundancies and project costs in relation to the Board exploring
strategic opportunities for parts of the business. This led to a
loss overall for the business of £5.9m before tax.
WM income was affected by market falls which led to
a reduction of total assets under management from £1.4bn to £1.2bn.
This was the principal reason for a fall in revenue of 18% (from
£14.4m to £11.9m). With the reduction of costs, including the
redundancies of staff, WM recorded a small underlying loss for the
year.
CM revenue is derived from retainer income, earned
from our role as NOMAD or broker to clients, and transactional
income. While retainer income held up well, we finished the year
with 79 clients, a fall from 90 at the beginning of the period,
transactional income was severely hit, with a particularly sharp
fall in corporate fundraisings. This led to an overall drop in CM
revenue of 22% from £12.2m to £9.6m.
Board
The Company welcomed two new non-executive directors
in November 2023, Simon Moore and Garry Stran to the Board, with
Simon serving as Chair. The Directors thank the previous
non-executive directors of the Company for their service to the
business.
On behalf of the Board, we would like to express our
appreciation for the continuing hard work and loyalty of employees
throughout a difficult period. Whilst this has been an unsettling
period for all stakeholders we would like to thank our employees,
clients and partners for their efforts to complete the sale of the
CM division and for working with us to stabilise the business.
We would also like to thank the team members who
were unfortunately made redundant during the year for their
professionalism during this period and wish them well for the
future.
As outlined in this report your board will now focus
on creating a business that has sustainable profitability, a
vibrant culture and is well placed to exploit strategic
opportunities should they arise in order to maximise the
opportunity to create shareholder value.
Financial review
Overview
The WH Ireland Group consists of a principal
operating subsidiary, WH Ireland Limited.
WH Ireland Limited consists of two business
divisions: WM (WM), which provides investment management solutions
and financial advisory services to retail clients and CM (CM) which
provides a range of services to both public and private companies,
including day to day regulatory and strategic corporate advice,
institutional sales and broking services; and the production of
equity research. It also provides trading services to Funds, High
Net worth individuals and Family Offices. Post balance sheet date,
the CM division has been sold.
Total assets managed by the Group are £1.8bn (FY23:
£2.1bn). Of this total, £1.2bn (FY23: £1.4bn) is held in WM with a
further £0.6bn (FY23: £0.7bn) within CM's Ultra High Net Worth
business.
The Group's income is derived from activities
conducted in the UK with a number of retail, high net worth,
ultra-high net worth, institutional and corporate clients.
The average Group headcount for the year was 133
(FY23: 163) in the UK.
Strategy summary
Following the fundraise that took place during the
year, the Group's aim was to increase the value of discretionary
assets under management in WM. The Group also aimed to continue to
service our new and existing corporate client list in CM, whilst
sourcing new transactional activity utilising our strong
distribution capability in public and private markets. During the
year, the Group pursued a sale of both the WM and CM divisions.
Both sales were judged to be highly probable at year end and so
have been classified as 'held for sale'. Post year end, the
strategy for WM shifted from a sale of the division to driving
growth in the assets under management and providing a wider level
of service to develop further revenue streams. The sale of the CM
division completed post year end in July 2024. This will assist the
group in the implementation of its plans for the growth of the
remaining WM business whilst finding efficiencies in the remaining
business.
Group financial results
summary
|
Year to
31 Mar
2024
£'000
|
Year
to
31 Mar
2023
£'000
|
Revenue
|
21,465
|
26,688
|
Administrative expenses
|
(26,665)
|
(27,591)
|
Expected credit loss
|
(328)
|
(239)
|
Operating
loss
|
(5,528)
|
(1,142)
|
|
|
|
Net loss on investments
|
(583)
|
(2,683)
|
Release of deferred
consideration
|
160
|
-
|
Changes in fair value and finance
cost of deferred consideration
|
-
|
(173)
|
Other income
|
-
|
2,175
|
Loss before tax
|
(5,951)
|
(1,823)
|
Taxation
|
12
|
-
|
Loss and
total comprehensive income for the year
|
(5,939)
|
(1,823)
|
The format of these tables do not follow that in the
Statement of Comprehensive Income which is required to show effect
of discontinued operations on the business. These table show the
results of both divisions in the statutory format.
Reconciliation between underlying and statutory
profits
Underlying profit before tax is considered by the
Board to be an accurate reflection of the Group's performance when
compared to the statutory results, as this excludes income and
expense categories which are deemed of a non-recurring nature or
non-cash operating item. Reporting at an underlying level is also
considered appropriate for external analyst coverage and peer group
benchmarking. A reconciliation between underlying and statutory
profit before tax for the year ended 31 March 2024 with comparative
is shown below:
|
Year to
31 Mar
2024
£'000
|
Year
to
31 Mar
2023
£'000
|
Underlying loss before tax
|
(2,468)
|
(1,987)
|
Amortisation of acquired brand and
client relationships
|
(273)
|
(496)
|
Changes in fair value and finance
cost or release of deferred consideration
|
160
|
(173)
|
Restructuring costs
|
(2,909)
|
-
|
Client Settlement
|
(152)
|
-
|
Other income
|
-
|
1,957
|
Net changes in the value of
non-current investments
|
(309)
|
(1,124)
|
Total underlying adjustments
|
(3,483)
|
164
|
|
|
|
Statutory loss before tax
|
(5,951)
|
(1,823)
|
Tax
|
12
|
-
|
Loss and total comprehensive income for the
year
|
(5,939)
|
(1,823)
|
Underlying earnings per
share
|
|
|
|
Weighted average number of shares
('000) in issue during the period (note 12)
|
175,718
|
59,172
|
|
Basic underlying earnings per
share
|
(1.40p)
|
(3.36p)
|
|
|
|
|
|
|
|
Amortisation of acquired brand and client
relationships
These intangible assets are created in the course of
acquiring funds under management and are amortised over their
useful life which have been assessed between two to 12 years. This
charge has been excluded from underlying profit as it is a
significant non-cash item. Amortisation ceased from the date the WM
division was reclassifies to assets held for sale, refer to note
6.
Changes in fair value and finance cost of
deferred consideration
This comprises the fair value measurement arising on
the deferred consideration payments from acquisitions together with
the associated finance costs from the unwinding of the present
value discount relating to the Harpsden acquisition (subsidiary
previously acquired).
Restructuring costs
These costs relate to the restructuring costs within
both WM and CM and the resultant costs of redundancies of staff in
the London office arising from the cost savings measures taken
during the year. These costs also include transaction fees paid in
relation to the exploration of the potential sale of the WM
division and the resultant sale of the CM division.
Client Settlement
This item relates to an issue with our outsourced
platform provider, cited in our interim results, which resulted in
incorrect amounts of interest being paid to clients. The provider
and the Group have settled these amounts with clients.
Other income
Last year the Group received a refund of £2.2m from
HMRC. This was following confirmation from HMRC that the supply of
certain Group services were exempt from VAT during the period from
2017 to 2022. This is presented net of commission payable to a
third party of £218k.
Net changes in value of
investments
As part of the fee arrangement with corporate
clients in CM, there is often a grant of warrants over shares or
the issue of actual shares in addition to the cash element of the
fee. The value of such warrants and shares are credited to revenue
on the date of the fee note and then any changes in the valuation
are recorded as net gains or losses. In view of the nature of these
gains or losses, including non-cash, these gains or losses have
been excluded from underlying profit. The total change in value of
investments are £583k, a corresponding commission payable of £274k
on the gain or loss of these warrants are included in the net
changes above. The net change in investment value is £309k.
The Financial Year 2024
Overall revenue fell from £26.7m to £21.5m from the
previous (19.6%), we reduced administrative expenses by 2% from
£27.6m to £26.7m. Although our loss on investments reduced from a
£2.7m loss in the previous year to £0.6m loss, we incurred
restructuring costs of £2.9m. These were principally redundancies
and transaction costs in relation to the Board exploring strategic
opportunities for parts of the business. This led to a loss overall
for the business of £6.0m before tax.
WM income was affected by market falls which led to
a reduction of assets under management from £1.4bn to £1.2bn. This
was the principal reason for a fall in revenue of 18% (from £14.4m
to £11.9m). With the reduction of costs, including the redundancies
of staff, WM recorded a small underlying loss for the year.
CM revenue is derived from retainer income, earned
from our role as NOMAD or broker to clients, and transactional
income. While retainer income held up well, we finished the year
with 79 clients, a fall from 90 at the beginning of the period,
transactional income was severely hit, with a particularly sharp
fall in corporate fundraisings. This led to an overall drop in CM
revenue of 22% from £12.2m to £9.6m.
Expenses
Total operational costs decreased by 3.2%. As part
of cost of sales, third party commission increased by 63.14%,
due to agreements that are revenue contingent. Variable people
costs, mainly related to bonus payments have reduced by 49%.
|
2024
£'000
|
2023
£'000
|
Cost of sales - non-salaried staff
costs (note 7)
|
1,592
|
605
|
Fixed non-people costs
|
11,235
|
10,867
|
Fixed people costs
|
12,881
|
14,243
|
Variable people costs
|
956
|
1,876
|
Total
|
26,664
|
27,591
|
Financial position and regulatory capital
Net assets remained consistent at £14.3m at 31 March
2024 (FY23: £14.3m) and tangible net assets (net assets excluding
disposal group, prior year net assets excluding intangible assets
and goodwill) decreased by 10% to £6.3m (FY23: £7.0m).
The Investment Firms Prudential Regime (IFPR)
applies to all solo-regulated MiFID investment firms and WH Ireland
is a non-SNI (small and non-interconnected) MIFIDPRU investment
firm.
Accordingly, the Group's regulatory capital
requirement is its fixed overhead requirement as defined by the
Financial Conduct Authority (FCA). During the year the Group
carried out a placing to raise £5m by way of the issue of ordinary
shares, to ensure that the Group's own funds are in excess of its
regulatory capital requirement. Post year end, the sale of the CM
division took place. This has had the effect of fixed overhead
requirements and wind-down costs for the business falling.
Cost reduction exercises have been implemented
during the year, including certain members of senior management
agreeing to sacrifice a proportion of their salary in return for
share options, alongside a collective consultation regarding
headcount reduction.
As a result, the Directors have reviewed the
forward-looking position as part of the going concern modelling and
stress testing and in light of post year-end events believe that
the regulatory requirements will be met.
Future developments
The Group has continued to be
subjected to challenging market conditions resulting from a number
of well documented public events. The funds from the placing that
took place during the year have been used to provide working
capital, secure the current regulatory capital position and achieve
a more stable financial position for the Group against the current
market backdrop. The Group has also actively explored asset sales
during the year, with the CM division being sold post year end.
This sale has resulted in a positive regulatory capital position
and changed requirements. The Directors will now focus on
implementing improvements to the remaining WM division as well as
making changes that will increase efficiencies across the
business.
Key Performance Indicators
The following financial and strategic measures have
been identified as the key performance indicators (KPIs) of the
Group's overall performance for the financial year.
1. GROUP ASSETS UNDER MANAGEMENT
The total value of funds under
management has a direct impact on the Group's revenue.
-14%
|
£bn
|
2. NUMBER OF RETAINED CM CORPORATE CLIENTS
The number of retained clients has
a direct relationship to the value of fees earned from success fees
and retainer income in CM.
-11
|
|
3. TOTAL REVENUE
The amount of revenue generated by
WM and CM together is one of the key growth indicators.
-20%
|
£m
|
4. DISCRETIONARY AND ADVISORY ASSETS UNDER MANAGEMENT
(WM)
Discretionary and advisory funds
are the main income driver for our WM business.
-16%
|
£bn
|
Dividends
The Board does not propose to pay a dividend in
respect of the financial year (FY23: £nil).
Statement of Financial Position and Capital
Structure
Maintaining a strong and liquid statement of
financial position remains a key objective for the Board, alongside
its regulatory capital requirement. Due to the successful placing
of shares during the year, the Group have been able to secure the
current regulatory capital position and achieve a more stable
financial position for the Group against the current market
backdrop. The group regulatory capital position is surplus to the
regulatory capital requirement. As a result of the post year end
sale of the CM division, the required regulatory capital position
has fallen to £3.8m (based on harm assessment). The group therefore
will be more likely to achieve these requirements. As at 31 March
2024, total net assets were £14.3m (FY23: £14.3m) and net current
assets £14.3m (FY23: £5.3m). This increase is due to assets and
liabilities being allocated to the disposal groups. Cash balances
at year-end were £4.9m (FY23: £4.2m).
Risks and Uncertainties
Risk appetite is established, reviewed and monitored
by the Board. The Group, through the operation of its Committee
structure, considers all relevant risks and advises the Board as
necessary. The Group maintains a comprehensive risk register as
part of its risk management framework encouraging a risk-based
approach to the internal controls and management of the Group. The
risk register covers all categories including human capital risk,
regulatory risk, conduct (client) risk, competition, financial
risk, IT and operational resilience risk and legal risk. Each risk
is ranked on impact and likelihood and mitigating strategies are
identified. In addition, the Executive Committee which is formed of
the Executive Directors, the Heads of the business divisions, a
representative from HR and Chief Risk and Compliance Officer meet
to assess and monitor these. An Executive Risk Committee has
recently been established to manage and monitor risks and report
into the Board.
The Group had outsourced its internal audit function
to Deloitte since April 2021. Post year end this function is now
outsourced to BDO. The internal auditors formally report to Garry
Stran, Chair of the Audit Committee with Jay Iyer, Chief Risk and
Compliance Officer, being the principal day to day contact.
Liquidity and capital
risk
The Group continues to focus on managing the costs
of its business and returning to growth and sustainable
profitability whilst increasing the proportion of recurring revenue
with CM and the building of its discretionary fee paying client
base in WM to better fit the regulatory environment in which it
operates.
To mitigate risk, the Board continues to focus on
ensuring that the financial position remains robust and suitably
liquid with sufficient regulatory capital being maintained over the
minimum common equity tier 1 capital requirements. Regulatory
capital and liquid assets are monitored on a daily basis.
Operational risk
Operational risk is the risk of loss to the Group
resulting from inadequate or failed internal processes, people and
systems, or from external events.
Business continuity risk is the risk that serious
damage or disruption may be caused as a result of a breakdown or
interruption, from either internal or external sources, of the
business of the Group. This risk is mitigated in part by the number
of branches across the UK and the Group having business continuity
and disaster recovery arrangements including business interruption
insurance.
The Group seeks to ensure that its risk management
framework and control environment is continuously evolving which
Compliance and Risk monitor on an ongoing basis.
Credit risk
The Board takes active steps to minimise credit
losses including formal new business approval, and the close
supervision of credit limits and exposures, and the proactive
management of any overdue accounts. Additionally, risk assessments
are performed on an ongoing basis on all deposit taking banks and
custodians and our outsourced relationships.
Regulatory risk
The Company operates in a highly regulated
environment in the UK. The Directors monitor changes and
developments in the regulatory environment and ensure that
sufficient resources are available for the Group to implement any
required changes. The impact of the regulatory environment on the
Group's management of its capital is discussed in note 26 of the
financial statements.
Section 172 Statement
Broader Stakeholder
Interests
Directors of the Group must consider Section 172 of
the Companies Act 2006 which requires them to act in the way that
would most likely promote the success of the Group for the benefit
of all its stakeholders. The Board and its committees consider who
its key stakeholders are, the potential impact of decisions made on
them taking into account a wider range of factors, including the
impact on the Company's operations and the likely consequences of
decisions made in the long-term. The Group's key stakeholders and
how the Board and the Group have engaged with them during the year
is set out below.
Employees
The CEO and his management team on behalf of the
Board engage with employees through a variety of methods including
periodic 'all staff' updates, information and points of interest,
staff forums, group meetings and Town Hall meetings.
Shareholders
Our shareholders have been pivotal in supporting the
Group and its management team and Board. The Board recognise and
frequently discuss the importance of good, open and constructive
relationships with both potential new shareholders as well as
existing shareholders and is committed to this communication. The
way in which this has been achieved during the year has been by our
Chief Executive Officer, supported by the management team,
maintaining regular contact and meetings with individual and
institutional shareholders, both existing and potential, and
communicating and discussing shareholders' views with the Board. A
number of Board members and employees also hold the Group's shares
and regular communications are provided. Having one class of share
capital ensures all shareholders are treated equally.
The Group's strategy and results are presented to
shareholders through meetings following announcements of the final
and interim results. Shareholders are also invited to meet the
Board and management team, who attend the Annual General Meeting.
The annual report and accounts for the year ended 31 March 2024
along with all past accounts, regulatory communications and other
material is set out on the Group's website at
https://www.whirelandplc.com/investor-relations.
Regulators
The Board maintains continuous and open
communication with our regulators at the FCA as well as with the
London Stock Exchange. Regular ongoing dialogue has continued
through the CEO and CFO with the FCA who receive regular Management
information. The FCA have approved the appointments of each member
of the Management team and the Board members as required.
Clients
Our clients are fundamental to the business of the
Group and the Board recognise that their interests are of paramount
importance. Management of WM and CM closely engage with clients to
understand their objectives so that the service provided by the
business is appropriate. In WM the client's profile and the
suitability of the investment strategy provided is frequently
assessed by our professional investment managers and this is
supplemented by a second line of review from management and our
compliance team. It is recognised that the status of our clients
can and does change in line with the environment and vulnerable
clients in particular are identified and discussed at management
and at Committee level to ensure that they are provided with the
best possible advice.
In CM the Group's objective is also to achieve the
best outcome and this applies equally to institutional corporate
clients. Regular contact is maintained with them across all
departments including corporate broking, corporate finance, trading
and research. Our investor relations team arranges meetings with
investors, undertakes site visits and organises events for a wide
range of our clients' teams.
Suppliers, Community and Environment
The Board through its Executive Directors is keenly
focused on its key supplier relationships and regularly challenges
and reviews its arrangements. The Group openly encourages its
offices and employees to engage in local charitable, community
groups and other causes.
The Board recognises the firm's duty to act in the
best long-term interests of our clients which includes having
investment practices that contribute to the preservation of our
planet. The Board has had an active effort to continue on our path
towards carbon neutrality by consuming less as an organisation,
providing recycling points in our offices and planting a new tree
for every new investment account opened.
Each of the Board members consider that they have
acted together, in good faith in a way most likely to promote the
success of the Group for the benefit of its broader range of
stakeholders as a whole taking into account section 172 (1) (a-f)
of the Companies Act 2006.
Maintaining a reputation for high standards of business
conduct
The board supports a culture that encourages the
group's high standards which helps the Group deliver on its
strategic objectives. The board ensures adherence to policies that
encourage high performance of employees and regularly receives
updates on the group's culture through engagement surveys and in
the business updates.
Considering the Long Term
The board outlines the Group's strategy and oversees
the framework of governance, risk management and internal
controls to with the long-term success of the business in mind. The
strategy is focused on developing the Group's ability to service
the long-term needs of its clients. The group operates in a highly
regulated environment. The identification, management and
mitigation of risks to the group's business is key to
ensuring the delivery of its strategy over the longer term,
and the consideration of risk plays an important part in
decision-making.
The Strategic Report has been approved by the Board
and signed on its behalf by:
S Jackson
Chief Finance
Officer
9 August 2024
Consolidated statement of comprehensive
income
|
|
Year ended
|
|
Year
ended
|
|
|
31 March
2024
|
|
31 March
2023
|
|
Note
|
£'000
|
|
£'000
*Restated
|
Net loss on investments
|
17
|
(583)
|
|
(2,683)
|
Release of deferred
consideration
|
8
|
160
|
|
(173)
|
Pre-tax loss from continuing operations
|
|
(423)
|
|
(2,856)
|
Taxation
|
10
|
12
|
|
-
|
Post-tax loss from continuing operations
|
|
(411)
|
|
(2,856)
|
(Loss)/profit from discontinued operations inc.
tax
|
6
|
(5,528)
|
|
1,033
|
Loss and total comprehensive income for the
year
|
|
(5,939)
|
|
(1,823)
|
Earnings per share
|
12
|
|
|
|
|
From continuing operations
|
|
|
|
|
|
Basic and diluted
|
|
(0.23p)
|
|
(4.83p)
|
|
From discontinuing operations
|
|
|
|
|
|
Basic and diluted
|
|
(3.15p)
|
|
1.75p
|
|
Total
|
|
|
|
|
|
Basic and diluted
|
|
(3.38p)
|
|
(3.08p)
|
|
|
|
|
|
|
|
|
|
|
|
*The 2023 consolidated statement of comprehensive
income has been restated to reflect the recognition of a deferred
tax asset to offset the deferred tax liability. Refer to Note 19
for further details.
There were no items of other comprehensive income
for the current year or prior years.
Consolidated statement of
financial position
|
|
Group
|
|
|
31 March
|
31
March
|
31
March
|
|
|
2024
|
2023
|
2022
|
|
Note
|
£'000
|
£'000
*Restated
|
£'000
*Restated
|
ASSETS
|
|
|
|
|
Non-current assets
|
|
|
|
|
Intangible assets
|
15
|
-
|
3,763
|
4,259
|
Goodwill
|
14
|
-
|
3,539
|
3,539
|
Property, plant and
equipment
|
13
|
-
|
569
|
325
|
Investments
|
17
|
-
|
820
|
3,013
|
Right of use asset
|
18
|
-
|
635
|
1,168
|
Deferred tax asset
|
19
|
|
-
|
-
|
|
|
-
|
9,326
|
12,304
|
Current assets
|
|
|
|
|
Trade and other
receivables
|
20
|
5,098
|
5,444
|
5,758
|
Other investments
|
21
|
1,544
|
2,049
|
1,912
|
Cash and cash
equivalents
|
22
|
4,902
|
4,234
|
6,446
|
Assets held for sale
|
6
|
7,994
|
-
|
-
|
Total current assets
|
|
19,538
|
11,727
|
14,116
|
Total assets
|
|
19,538
|
21,053
|
26,420
|
LIABILITIES
|
|
|
|
|
Current liabilities
|
|
|
|
|
Trade and other
payables
|
23
|
(3,232)
|
(4,013)
|
(6,681)
|
Lease liability
|
18
|
-
|
(319)
|
(376)
|
Provisions
|
24
|
(1,676)
|
(2,121)
|
(2,412)
|
Liabilities classified as held for
sale
|
6
|
(293)
|
-
|
-
|
Total current liabilities
|
|
(5,201)
|
(6,453)
|
(9,469)
|
Non-current liabilities
|
|
|
|
|
Deferred tax liability*
|
19
|
-
|
-
|
-
|
Lease liability
|
18
|
-
|
(293)
|
(999)
|
|
|
-
|
(293)
|
(999)
|
Total liabilities
|
|
(5,201)
|
(6,746)
|
(10,468)
|
Total net assets
|
|
14,337
|
14,307
|
15,952
|
|
|
|
|
|
Capital and reserves
|
|
|
|
|
Share capital
|
27
|
4,965
|
3,116
|
3,104
|
Share premium
|
27
|
22,817
|
19,014
|
19,014
|
Other reserves
|
|
981
|
981
|
981
|
Retained earnings
|
|
(13,312)
|
(7,711)
|
(6,247)
|
Treasury shares
|
28
|
(1,114)
|
(1,093)
|
(900)
|
Shareholders' funds
|
|
14,337
|
14,307
|
15,952
|
* The 2023 and 2022 consolidated statement of
financial position has been restated to reflect the recognition of
a deferred tax asset to offset the deferred tax liability. Refer to
Note 19 for further details.
These financial statements were approved by the
Board of Directors on 9 August 2024 and were signed on its behalf
by:
S
Jackson
Director
Company statement of financial position
|
|
Company
|
|
|
31 March
|
31
March
|
|
|
2024
|
2023
|
|
Note
|
£'000
|
£'000
|
ASSETS
|
|
|
|
Non-current assets
|
|
|
|
Investment in
subsidiaries
|
16
|
19,848
|
26,448
|
Loan receivable
|
28
|
1,114
|
1,093
|
Amounts owed from Group
companies
|
20
|
4,676
|
-
|
|
|
25,638
|
27,541
|
Current assets
|
|
|
|
Trade and other
receivables
|
20
|
44
|
29
|
|
|
44
|
29
|
Total assets
|
|
25,682
|
27,570
|
LIABILITIES
|
|
|
|
Current liabilities
|
|
|
|
Trade and other
payables
|
23
|
(750)
|
(1,136)
|
Provisions
|
24
|
(1,229)
|
(2,121)
|
Total liabilities
|
|
(1,979)
|
(3,257)
|
Total net assets
|
|
23,703
|
24,313
|
|
|
|
|
Capital and reserves
|
|
|
|
Share capital
|
27
|
4,965
|
3,116
|
Share premium
|
27
|
22,817
|
19,014
|
Other reserves
|
|
228
|
228
|
Retained earnings
|
|
(4,307)
|
1,955
|
Shareholders' funds
|
|
23,703
|
24,313
|
The Company has elected to take the exemption under
Section 408 of the Companies Act 2006 not to present the Company
statement of comprehensive income. The loss after tax of the
Company for the year was £6.6m (FY23: £nil).
These financial statements were approved by the
Board of Directors on 9 August 2024 and were signed on its behalf
by:
S Jackson
Director
Consolidated and Company statement of cash
flows
|
|
Group
|
Company
|
|
|
Year ended
|
Year
ended
|
Year ended
|
Year
ended
|
|
|
31 Mar
2024
|
31 Mar
2023
|
31 Mar
2024
|
31 Mar
2023
|
|
Notes
|
£'000
|
£'000
*restated
|
£'000
|
£'000
|
Operating activities:
|
|
|
|
|
|
Loss for the year
|
|
(5,939)
|
(1,823)
|
(6,600)
|
-
|
|
|
(5,939)
|
(1,823)
|
(6,600)
|
-
|
Adjustments for non-cash items:
|
|
|
|
|
|
Depreciation and
amortisation
|
13, 15, 18
|
624
|
1,093
|
-
|
-
|
Finance income
|
8
|
-
|
(10)
|
-
|
-
|
Movement in deferred
consideration
|
8
|
(160)
|
173
|
(160)
|
173
|
Finance expense
|
8
|
21
|
51
|
-
|
-
|
Tax
|
10
|
(12)
|
-
|
-
|
-
|
Non-cash adjustment for share
option charge
|
7
|
338
|
359
|
338
|
359
|
Non-cash adjustment for investment
gains
|
17, 21
|
583
|
2,683
|
-
|
-
|
Non-cash consideration for
revenue
|
|
(761)
|
(1,096)
|
-
|
-
|
Non-cash adjustment for right of
use assets
|
18
|
-
|
(125)
|
-
|
-
|
Impairment
|
16
|
-
|
-
|
6,600
|
-
|
Working capital changes:
|
|
|
|
|
|
Decrease / (increase) in trade and
other receivables
|
|
346
|
314
|
(4,851)
|
88
|
(Decrease) / increase in trade and
other payables and provisions**
|
|
(336)
|
(2,668)
|
(228)
|
(1,221)
|
Net cash (used in) / generated from
operations
|
|
(5,296)
|
(1,049)
|
(4,901)
|
(601)
|
Income taxes
received/(paid)
|
10
|
-
|
-
|
-
|
|
Net cash outflows from operating activities
|
|
(5,296)
|
(1,049)
|
(4,901)
|
(601)
|
Investing activities:
|
|
|
|
|
|
Acquisition of property, plant and
equipment
|
13
|
(16)
|
(475)
|
-
|
-
|
Decrease / (increase) in loan
receivables
|
|
-
|
-
|
(21)
|
(193)
|
Interest received
|
8
|
12
|
10
|
-
|
-
|
Cash received on disposal of
investments and warrants
|
17, 21
|
1,408
|
430
|
-
|
-
|
Deferred consideration
paid*
|
24
|
(78)
|
(464)
|
(78)
|
(464)
|
Net cash generated from / (used in) investing
activities
|
|
1,326
|
(499)
|
(99)
|
(657)
|
Finance activities:
|
|
|
|
|
|
Proceeds from issue of share
capital
|
27
|
5,000
|
12
|
5,000
|
12
|
Purchase of own shares by Employee
Benefit Trust
|
|
(21)
|
(193)
|
-
|
-
|
Interest paid
|
8
|
-
|
-
|
-
|
-
|
Lease liability
payments
|
|
(340)
|
(483)
|
-
|
-
|
Net cash generated from/ (used in) financing
activities
|
|
4,639
|
(664)
|
5,000
|
12
|
Net increase / (decrease) in cash and cash
equivalents
|
|
668
|
(2,212)
|
-
|
(1,246)
|
Cash and cash equivalents at
beginning of year
|
|
4,234
|
6,446
|
-
|
1,246
|
Cash and cash equivalents at end
of year
|
|
4,902
|
4,234
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
*The 2023 consolidated statement
of financial position has been restated to reflect the recognition
of a deferred tax asset to offset the deferred tax liability. Refer
to Note 19 for further details.
In the prior year, Deferred
consideration paid of £464k had been presented as a Financing
activity. The cash flow relates to the payment of deferred
consideration relating to the acquisition of Harpsden WM Limited,
which is an Investing activity. The comparative has been restated
accordingly.
Non-cash transaction:
** During the period, outstanding deferred
consideration of £654k was settled via issue of shares (refer to
note 24)
Reconciliation of Group and Company
liabilities arising from financing activities in the
year:
|
As
at
|
Cash
flows
|
Non-cash
|
As
at
|
|
1 April
2023
|
|
changes
|
31 March
2024
|
Group
|
£'000
|
£'000
|
£'000
|
£'000
|
Lease liability
|
612
|
(340)
|
21
|
293
|
|
612
|
(340)
|
21
|
293
|
Reconciliation of Group and Company liabilities
arising from financing activities in the prior year:
|
As
at
|
Cash
flows
|
Non-cash
|
As
at
|
|
1 April
2022
|
|
changes
|
31 March
2023
|
|
|
|
|
|
Group
|
£'000
|
£'000
|
£'000
|
£'000
|
Lease liability
|
1,375
|
(483)
|
(280)
|
612
|
|
1,375
|
(483)
|
(280)
|
612
|
There are no Company liabilities arising from
financing activities.
Consolidated and Company
statement of changes in equity
|
Share
|
Share
|
Other
|
Retained
|
Treasury
|
Total
|
|
capital
|
premium
|
reserves
|
earnings
|
shares
|
equity
|
Group
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Balance at 1 April 2022 (As
originally stated)
|
3,104
|
19,014
|
981
|
(6,789)
|
(900)
|
15,410
|
Prior year adjustment*
|
-
|
-
|
-
|
542
|
-
|
542
|
Balance at 1 April 2022 (As
restated)
|
3,104
|
19,014
|
981
|
(6,247)
|
(900)
|
15,952
|
Loss and total comprehensive
income for the year (Previously stated as £1,944k)
|
-
|
-
|
-
|
(1,823)
|
-
|
(1,823)
|
Transactions with
owners in their capacity as owners:
|
|
|
|
|
|
Employee share option
scheme
|
-
|
-
|
-
|
359
|
-
|
359
|
New share capital
issued
|
12
|
-
|
-
|
-
|
-
|
12
|
Purchase of own shares by Employee
Benefit Trust
|
-
|
-
|
-
|
-
|
(193)
|
(193)
|
Balance at 31 March 2023 (As
restated)
|
3,116
|
19,014
|
981
|
(7,711)
|
(1,093)
|
14,307
|
|
|
|
|
|
|
|
Loss and total comprehensive income for the year
|
-
|
-
|
-
|
(5,939)
|
-
|
(5,939)
|
Transactions with
owners in their capacity as owners:
|
|
|
|
|
|
Employee share option
scheme
|
-
|
-
|
-
|
338
|
-
|
338
|
New share capital
issued**
|
1,849
|
3,928
|
-
|
-
|
-
|
5,777
|
Share issue costs
|
-
|
(125)
|
-
|
-
|
-
|
(125)
|
Purchase of own shares by Employee
Benefit Trust
|
-
|
-
|
-
|
-
|
(21)
|
(21)
|
Balance at 31 March 2024
|
4,965
|
22,817
|
981
|
(13,312)
|
(1,114)
|
14,337
|
*The 2023 Consolidated and Company statement of
changes in equity has been restated to reflect the recognition of a
deferred tax asset to offset the deferred tax liability. Refer to
Note 19 for further details.
**See further details in note 27.
Retained earnings include £10k (2023: £10k) ESOT
reserve.
|
Share
|
Share
|
Other
|
Retained
|
Treasury
|
Total
|
|
capital
|
premium
|
reserves
|
earnings
|
shares
|
equity
|
Company
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Balance at 1 April 2022
|
3,104
|
19,014
|
228
|
1,596
|
-
|
23,942
|
Profit / (loss) and total
comprehensive income for the year
|
-
|
-
|
|
-
|
-
|
-
|
Transactions with
owners in their capacity as owners:
|
|
|
|
|
|
Employee share option
scheme
|
-
|
-
|
-
|
359
|
-
|
359
|
New share capital
issued
|
12
|
-
|
-
|
-
|
-
|
12
|
Balance at 31 March
2023
|
3,116
|
19,014
|
228
|
1,955
|
-
|
24,313
|
|
|
|
|
|
|
|
Profit / (loss) and total
comprehensive income for the year
|
-
|
-
|
-
|
(6,600)
|
-
|
(6,600)
|
Transactions with
owners in their capacity as owners:
|
|
|
|
|
|
Employee share option
scheme
|
-
|
-
|
-
|
338
|
-
|
338
|
New share capital issued (note
27)
|
1,849
|
3,928
|
-
|
-
|
-
|
5,777
|
Share issue costs
|
-
|
(125)
|
-
|
-
|
-
|
(125)
|
Balance at 31 March 2024
|
4,965
|
22,817
|
228
|
(4,307)
|
-
|
23,703
|
The nature and purpose of each reserve, whether
consolidated or Company only, is summarised below:
Share premium
The share premium is the amount raised on the issue
of shares that is in excess of the nominal value of those shares
and is recorded less any direct costs of issue.
Other reserves
Other reserves comprise a (consolidated) merger
reserve of £753k (FY23: £753k) and a (consolidated and company)
capital redemption reserve of £228k (FY23: £228k).
Retained earnings
Retained earnings reflect accumulated income,
expenses, gains and losses, recognised in the statement of
comprehensive income and the statement of recognised income and
expense and is net of dividends paid to shareholders. It includes
£10k (FY23: £10k) of ESOT reserve.
Treasury shares
Purchases of the Company's own shares in the market
are presented as a deduction from equity, at the amount paid,
including transaction costs. That is, shares are shown as a
separate class of shareholders' equity with a debit balance. This
includes shares in the Company held by the EBT or ESOT, both of
which are consolidated within the consolidated figures.
Notes to the financial
statements
1. General
information
WH Ireland Group plc is a public company
incorporated in the United Kingdom. The shares of the Company are
traded on the AIM, a market of the London Stock Exchange Group plc.
The address of its registered office is 24 Martin Lane, London,
EC4R 0DR.
Basis of preparation
The consolidated and Parent Company financial
statements have been prepared in accordance with International
Accounting Standards as adopted by the UK and in accordance with
the Companies Act 2006. The principal accounting policies adopted
in the preparation of the consolidated financial statements are set
out in note 3. The policies have been consistently applied to all
the years presented, unless otherwise stated.
The consolidated financial statements are presented
in British Pounds (GBP), which is also the Group's functional
currency. Amounts are rounded to the nearest thousand, unless
otherwise stated.
Going concern
The financial statements of the Group have been
prepared on a going concern basis. In making this assessment, the
Directors have prepared detailed financial forecasts for the period
to September 2025 which consider the funding and capital position
of the Group and Company. Those forecasts make assumptions in
respect of future trading conditions, notably the economic
environment and its impact on the Group's revenues and costs. In
addition to this, the nature of the Group's business is such that
there can be considerable variation in the timing of cash inflows.
The forecasts take into account foreseeable downside risks, based
on the information that is available to the Directors at the time
of the approval of these financial statements.
Certain activities of the Group are regulated by the
FCA, the statutory regulator for financial services business in the
UK which has responsibility for policy, monitoring and discipline
for the financial services industry. The FCA requires the Group's
capital resources to be adequate; that is sufficient in terms of
quantity, quality and availability, in relation to its regulated
activities. The Directors monitor the Group's regulatory capital
resources on a regular basis.
The Directors have conducted full and thorough
assessments of the Group's business and the past financial year has
provided a thorough test of those assessments. The ongoing market
conditions presented a range of challenges to the business and
during the year the Group raised additional capital by way of
placing of ordinary shares to existing shareholders and new
investors raising £5m. After the year end, the Group sold the CM
division which resulted in an up-front reduction in the required
regulatory capital. Additionally, this will also result in cost
reductions as expenses related to that division will reduce, with
benefits taking effect from quarter 2 of the financial year. The
cost savings have been factored into the forecasts.
Whilst there always remains uncertainty over the
economic environment, after the year-end the business has improved
its capital position and likelihood of a return to a break-even
position. Further actions open to the Directors include incremental
cost reductions, regulatory capital optimisation programmes or
further capital raising.
An analysis of the potential downside impacts was
conducted as part of the going concern assessment to assess the
potential impact on revenue and asset values with a particular
focus on the variable component parts of our overall revenue.
Furthermore, reverse stress tests were modelled to assess what
level the Group's business would need to reduce to before resulting
in a liquidity crisis or a breach of regulatory capital. That
modelling concluded that all revenue would need to decline by more
than 45% from management's forecasts to create such a crisis
situation within 18 months' time.
Based on all the aforementioned, the Directors
believe that regulatory capital requirements will continue to be
met and that the Group and Company has sufficient liquidity to meet
its liabilities for the next 12 months and that the preparation of
the financial statements on a going concern basis remains
appropriate.
2. Adoption of new and revised standards
New and amended standards that are effective
for the current year
A number of new or amended standards became
applicable for the current reporting period and as a result the
Group and Company has applied the following standards:
- IAS 1: Presentation of Financial Statements:
Classification of Liabilities as Current or Non-Current and
Classification of Liabilities as Current or Non-Current - Deferral
of Effect Date. Non-current Liabilities with covenants
The above requirements did not have a material impact
on the financial statements of the group or company.
New standards, interpretations and amendments
not yet effective
Name
|
Description
|
Effective date
|
IAS 1
|
Non-current Liabilities with covenants
|
1 January 2024
|
The Directors do not expect the adoption of these
standards and amendments to have a material impact on the Financial
Statements.
3. Significant accounting
policies
Basis of consolidation
Where the company has control over an investee, it
is classified as a subsidiary. The company controls an investee if
all three of the following elements are present: power over the
investee, exposure to variable returns from the investee and the
ability of the investor to use its power to affect those variable
returns. Control is reassessed whenever facts and circumstances
indicate that there may be a change in any of these elements of
control.
The consolidated financial statements present the
results of the Company and its subsidiaries ("the Group") as if
they formed a single entity. Intercompany transactions and balances
between group companies are therefore eliminated in full. The
consolidated financial statements incorporate the results of
business combinations using the acquisition method. In the
statement of financial position, the acquiree's identifiable
assets, liabilities and contingent liabilities are initially
recognised at their fair values at the acquisition date. The
results of acquired operations are included in the consolidated
statement of comprehensive income from the date on which control is
obtained until the date on which control ceased.
In the Company's accounts, investments in subsidiary
undertakings are stated at cost less any provision for
impairment.
Business combinations
All business combinations are accounted for by
applying the purchase method. The purchase method involves
recognition, at fair value, of all identifiable assets and
liabilities, including contingent liabilities, of the subsidiary at
the acquisition date, regardless of whether or not they were
recorded in the financial statements of the subsidiary prior to
acquisition. The cost of business combinations is measured based on
the fair value of the equity or debt instruments issued and cash or
other consideration paid, plus any directly attributable costs. Any
directly attributable costs relating to business combinations
before or after the acquisition date are charged to the statement
of comprehensive income in the period in which they are
incurred.
Goodwill arising on a business combination
represents the excess of cost over the fair value of the Group's
share of the identifiable net assets acquired and is stated at cost
less any accumulated impairment losses. The cash generating units
to which goodwill is allocated are tested annually for impairment.
Any impairment is recognised immediately in administrative expenses
in the statement of comprehensive income and is not subsequently
reversed. On disposal of a subsidiary the attributable amount of
goodwill that has not been subject to impairment is included in the
determination of the profit or loss on disposal.
Revenue
WM (WM)
Management and custody
fees
Investment management fees are recognised in the
period in which the related service is provided. It is a variable
fee based on the average daily market value of assets under
management and is invoiced on a calendar quarter basis in arrears.
The performance obligation is satisfied over time as the
contractual obligations are on ongoing throughout the period under
contract. The revenue accrued but not yet invoiced is recognised as
a contract asset.
Initial and ongoing advisory
fees
Initial advisory fees are charged to clients on a
fixed one-off fee agreement. The performance obligation is
satisfied as the initial advice is provided. Ongoing advisory fees
are variable fees based on the average daily market value of assets
under management and invoiced on a calendar quarter basis in
arrears. Both initial and ongoing advisory fees are recognised in
the period in which the related service is provided. The
performance obligation of ongoing advice is satisfied over time as
the contractual obligations are ongoing throughout the period under
contract. The revenue accrued but not yet invoiced is recognised as
a contract asset.
Commission and transaction
charges
Commission is recognised when receivable in
accordance with the date of settlement. It is a variable fee based
on a percentage of the transaction and therefore the performance
obligation is satisfied at the date of the underlying transaction.
The transaction price is calculated based on the agreed percentage
of the underlying consideration of the trade. The underlying
consideration being the number of shares multiplied by the share
price at the time of the underlying transaction.
CM (cM)
Commission
Brokerage commission is recognised when receivable
in accordance with the date of settlement. It is a variable fee
based on a percentage of the transaction and therefore performance
obligation is satisfied at the date of the underlying transaction.
The transaction price is calculated based on the agreed percentage
of the underlying consideration of the trade. The underlying
consideration being the number of shares multiplied by the share
price at the time of the underlying transaction.
Corporate finance advisory
fees
Corporate finance advisory fees are fixed fees
agreed on a deal by deal basis and might include non-cash
consideration received in the form of shares, loan notes, warrants
or other financial instruments recognised at the fair value on the
date of receipt and therefore the performance obligation is
satisfied over time when the Group has met the performance
obligations per the contract.
Retainer fees
Retainer fees are recognised over the length of time
of the agreement. Fees are fixed and invoiced quarterly in advance
based on the agreed engagement letter. The performance obligation
is satisfied over time as the contractual obligations are on
ongoing throughout the period under contract. The deferred revenue
is recognised as a contract liability.
Corporate placing
commissions
Corporate placing
commissions are variable fees agreed on a deal-by-deal basis based
on a percentage of the funds raised as part of a transaction. This
includes non-cash consideration received in the form of shares,
loan notes, warrants or other financial instruments recognised at
the fair value on the date of receipt. Given that fees related to
this work are success based, there is a significant risk of
reversal of the variable revenue and therefore the performance
obligation is satisfied at a point in time when the transaction is
completed. The combination of corporate placing commissions and
corporate finance advisory fees are referred to as corporate
success fees.
Employee benefits
The Group contributes to employees' individual money
purchase personal pension schemes. The assets of the schemes are
held separately from those of the Group in independently
administered funds. The amount charged to the statement of
comprehensive income represents the contributions payable to the
schemes in respect of the period to which they relate.
Short-term employee benefits are those that fall due
for payment within 12 months of the end of the period in which
employees render the related service. The cost of short-term
benefits is not discounted and is recognised in the period in which
the related service is rendered. Short-term employee benefits
include cash-based incentive schemes and annual bonuses.
Share-based payments
The share option programmes allow Group employees to
receive remuneration in the form of equity-settled share-based
payments granted by the Company.
The cost of equity-settled transactions with
employees is measured by reference to the fair value at the date at
which they are granted. The fair value of the options granted is
measured using an option valuation model. The cost of
equity-settled transactions is recognised, together with a
corresponding increase in equity, over the period in which the
performance or service conditions are fulfilled (the vesting
period), ending on the date on which the relevant employees become
fully entitled to the award (the vesting date). The cumulative
expense recognised for equity settled transactions, at each
reporting date until the vesting date, reflects the extent to which
the vesting period has expired and the Group's best estimate of the
number of equity instruments that will ultimately vest. The
statement of comprehensive income charge or credit for a period
represents the movement in cumulative expense recognised at the
beginning and end of that period.
Where the terms of an equity-settled award are
modified, an incremental value is calculated as the difference
between the fair value of the repriced option and the fair value of
the original option at the date of re-pricing. This incremental
value is then recognised as an expense over the remaining vesting
period in addition to the amount recognised in respect of the
original option grant.
Where an equity-settled award is cancelled or
settled (that is, cancelled with some form of compensation) it is
treated as if it had vested on the date of cancellation and any
expense not yet recognised for the award is recognised
immediately.
However, if a new award is substituted for the
cancelled award and is designated as a replacement award on the
date that it is granted, the cancelled and new awards are treated
as if they were a modification of the original award, as described
in the previous paragraph. Any compensation paid up to the fair
value of the award is accounted for as a deduction from equity.
Where an award is cancelled by forfeiture, when the vesting
conditions are not satisfied, any costs already recognised are
reversed (subject to exceptions for market conditions).
In all instances, the charge/credit is taken to the
statement of comprehensive income of the Group or Company by which
the individual concerned is employed.
Employee Share Ownership Trust
(ESOT)
The Company has established an ESOT. The assets and
liabilities of this trust comprise shares in the Company and loan
balances due to the Company. The Group includes the ESOT within
these consolidated Financial Statements and therefore recognises a
Treasury shares reserve in respect of the amounts loaned to the
ESOT and used to purchase shares in the Company. Any cash received
by the ESOT on disposal of the shares it holds, will be used to
repay the loan to the Company.
The costs of purchasing Treasury shares are shown as
a deduction against equity. The proceeds from the sale of own
shares held increase equity. Neither the purchase nor sale of
treasury shares leads to a gain or loss being recognised in the
consolidated statement of comprehensive income.
Income taxes
Income tax on the profit or loss for the years
presented, comprising current tax and deferred tax, is recognised
in the statement of comprehensive income except to the extent that
it relates to items recognised directly in equity, in which case it
is recognised in equity.
Current tax is the expected tax payable on the
taxable income for the year, using rates enacted or substantively
enacted at the reporting year-end date and any adjustment to tax
payable in respect of previous years.
Deferred tax is provided for temporary differences,
at the reporting year-end date, between the tax bases of assets and
liabilities and their carrying amounts for financial reporting
purposes. The following temporary differences are not provided
for;
· goodwill which is not
deductible for tax purposes;
· the initial
recognition of assets or liabilities that affect neither accounting
nor taxable profit; and
· temporary differences
relating to investments in subsidiaries to the extent that they
will probably not reverse in the foreseeable future.
The amount of deferred tax provided is based on the
expected manner of realisation or settlement of the carrying amount
of assets and liabilities, using tax rates enacted or substantively
enacted at the reporting period end date (note 19).
A deferred tax asset is recognised for all
deductible temporary differences and unused tax losses only to the
extent that it is probable that future taxable profits will be
available against which the assets can be utilised.
Plant and equipment
Plant and equipment is stated at cost less
accumulated depreciation and impairment. Depreciation is
calculated, using the straight-line method, to write down the cost
or revalued amount of plant and equipment over the assets' expected
useful lives, to their residual values, as follows:
Computers, fixtures and
fittings
-
4 to 7 years
Intangible assets
Measurement
Intangible assets with finite useful lives that are
acquired separately are measured, on initial recognition at cost.
Following initial recognition, they are carried at cost less
accumulated amortisation and any accumulated impairment. The cost
of intangible assets acquired in a business combination is their
fair value at the date of acquisition.
Intangible assets other than goodwill are amortised
over the expected pattern of their consumption of future economic
benefits, to write down the cost of the intangible assets to their
residual values as follows:
Client relationships
-
10 to 12 years
Brand
-
2 years
The amortisation period and method for an intangible
asset are reviewed at least at each financial year end. Changes in
the expected useful life or the expected pattern of consumption of
future economic benefits embodied in the asset or its residual
value are accounted for by changing the amortisation period or
method.
Impairment
The carrying amounts of the Group's intangible assets,
excluding goodwill, are reviewed when there is an indicator of
impairment and the asset's recoverable amount is estimated.
The recoverable amount is the higher of the asset's
fair value less costs to sell (or net selling price) and its
value-in-use. Value-in-use is the discounted present value of
estimated future cash inflows expected to arise from the continuing
use of the asset and from its disposal at the end of its useful
life. Where the recoverable amount of an individual asset cannot be
identified, it is calculated for the smallest cash-generating unit
(CGU) to which the asset belongs. A CGU is the smallest
identifiable group of assets that generates cash inflows
independently.
When the carrying amount of an asset (or CGU)
exceeds its recoverable amount, the asset (or CGU) is considered to
be impaired and is written down to its recoverable amount. An
impairment loss is immediately recognised as an expense. Any
subsequent reversal of impairment credited to the statement of
comprehensive income shall not cause the carrying amount of the
intangible asset to exceed the carrying amount that would have been
determined had no impairment been recognised.
Impairment of assets
Goodwill and other intangible assets that have an
indefinite life are not subject to amortisation, they are tested
annually for impairment. Other assets are tested for impairment
when any changes in circumstance indicate the carrying amount is
possibly not recoverable. An impairment loss is recognised when the
asset's carrying amount exceeds its recoverable amount. The
recoverable amount is the higher of an asset's fair value less
costs to sell and the value in use. Goodwill is allocated to cash
generating units for the purpose of assessing impairment, assets
(excluding goodwill) are grouped together based on the assets that
independently generates cash flow whose cash flow is largely
independent of the cash flows generated by other assets (cash
generating units).
Leased assets
Measurement and recognition of leases as a
lessee
For any new lease contracts entered into on or after
1 April 2019, as permitted under IFRS 16, the Group recognises a
right of use asset and a lease liability except for:
· Leases with a term of
12 months or less from the lease commencement date
· Leases of low value
assets
Lease liabilities are measured at the present value
of the unpaid lease payments discounted using an incremental
borrowing rate.
Right of use assets are initially measured at the
amount of the lease liabilities plus initial direct costs, costs
associated with removal and restoration and payments previously
made. Right of use assets are amortised on a straight-line basis
over the term of the lease.
Lease liabilities are subsequently increased by the
interest charge using the incremental borrowing rate and reduced by
the principal lease.
Financial instruments
Financial assets and financial liabilities are
recognised in the Group's balance sheet when the Group becomes a
party to the contractual provisions of the instrument.
Financial assets and liabilities
Investments are recognised and derecognised on the
trade date where the purchase or sale of an investment is under a
contract whose terms require delivery of the investment within the
timeframe established by the market concerned, and are initially
measured at fair value, plus transaction costs, except for those
financial assets classified as at fair value through profit or
loss, which are initially measured at fair value.
Assets and liabilities are presented net where there
is a legal right to offset and an intention to settle in that
way.
The three principal classification categories for
financial assets are: measured at amortised cost, fair value
through other comprehensive income (FVOCI) and fair value through
profit or loss (FVTPL). The classification of financial assets
under IFRS 9 is generally based on the business model in which a
financial asset is managed and its contractual cash flow
characteristics.
Financial assets are not reclassified after their
initial recognition unless the Group changes its business model for
managing financial assets, in which case all affected financial
assets are reclassified on the first day of the first reporting
period following the change in the business model.
A financial asset is measured at amortised cost if
it meets both of the following conditions and is not designated as
at FVTPL:
· it is held within a
business model whose objective is to hold assets to collect
contractual cash flows; and
· its contractual terms
give rise on specified dates to cash flows that are solely payments
of principal and interest on the principal amount outstanding.
On initial recognition of an equity investment that
is not held for trading, the Group may irrevocably elect to present
subsequent changes in the investment's fair value in OCI. This
election is made on an investment-by-investment basis.
All financial assets not classified as measured at
amortised cost or FVOCI as described above are measured at FVTPL.
On initial recognition, the Group may irrevocably designate a
financial asset that otherwise meets the requirements to be
measured at amortised cost or at FVOCI as at FVTPL if doing so
eliminates or significantly reduces an accounting mismatch that
would otherwise arise.
Assets held at FVTPL are subsequently measured at
fair value. Net gains and losses, including any interest or
dividend income, are recognised in profit or loss.
Financial assets at amortised cost are subsequently
measured at amortised cost using the effective interest method. The
amortised cost is reduced by impairment losses. Trade receivables
and other receivables are measured and carried at amortised cost
using the effective interest method, less any impairment. If
impaired, the carrying amount of other receivables is reduced by
the impairment loss directly and a charge is recorded in the Income
Statement. For trade receivables, the carrying amount is reduced by
the expected credit lifetime losses under the simplified approach
permitted under IFRS9. Subsequent recoveries of amounts previously
written off are credited against the allowance account and changes
in the carrying amount of the allowance account are recognised in
the Income Statement.
Equity investments at FVOCI are subsequently
measured at fair value. Dividends are recognised as income in
profit or loss unless the dividend clearly represents a recovery of
part of the cost of the investment. Other net gains and losses are
recognised in OCI and are never reclassified to profit or loss.
The following financial assets & liabilities are
held at FVTPL; investments and deferred consideration. The
following financial assets and liabilities are held at amortised
cost; Cash and cash equivalents, trade and other receivables,
contract assets, trade and other payables and lease
liabilities.
Trade payables
Trade payables principally comprise amounts
outstanding for trade purchases and ongoing costs. The Directors
consider that the carrying amount of trade payables approximates to
their fair value.
Deferred consideration
Deferred consideration is recognised at the
discounted present value of amounts payable. After initial
recognition, it is rebased over the period in which the
consideration is payable, with the unwinding of the discount being
taken to the statement of comprehensive income.
4. Critical accounting judgements
and key sources of estimation and uncertainty
The preparation of financial statements in
accordance with IFRS requires management to make judgements,
estimates and assumptions that affect the application of accounting
policies and the reported amounts of assets, liabilities, income
and expenses. Actual results may differ from these estimates.
Estimates and judgements are continually evaluated
and are based on historical experience and other factors, including
reasonable expectations of future events. The estimates and
judgements that have a significant risk of causing a material
adjustment to the carrying amounts of assets and liabilities within
the next financial year are discussed below:
Identification and classification of
discontinued operations and disposal group assets and
liabilities
Management was required to assess both
divisions against criteria set out in IFRS 5 on whether they would
be classed as discontinued operations. During the year, the Group
pursued a sale of both the WM and CM divisions. Both sales were
judged to be highly probable at year end and so have been
classified as 'held for sale'. The sale of the divisions were
deemed to be highly probable on the date bids were received from
the preferred bidders. This was 31st October 2023 for WM
and 15th February 2024 for CM. At year end both
divisions have been classed as such and assets and liabilities held
for sale have been allocated to the associated disposal
groups.
Post year end, the WM sale fell through and there was an initial
attempt to find an alternative buyer. However, following the
successful sale of the CM business and positive impact that has on
the group's cash flows and regulatory capital, management felt that
this transaction essentially gave more time to make a decision on
the future of the WM division. The intention to continue operating
the WM division became the preferred option. As this decision was
made post year end, it is not indicative of circumstances that
existed at the year end, an adjustment is therefore not necessary
to be made at 31 March 2024 and the WM division remains classified
as held for sale at that date.
The Statement of Comprehensive Income shows the results from the
discontinued operations. The Statement of Financial Position has
the assets and liabilities held for sale. These have been allocated
to the disposal groups as detailed in note 6.
Amortisation and impairment of non-financial
assets
As noted above, the Group estimates the useful
economic lives of intangible assets, in order to calculate the
appropriate amortisation charge. This is done by the Directors
using their knowledge of the markets and business conditions that
generated the asset, together with their judgement of how these
will change in the foreseeable future. Note 14 outlines the details
of the value in use calculation and the assumptions made in
this.
Where an indicator of impairment exists, value in
use calculations are performed to determine the appropriate
carrying value of the asset. The value in use calculation requires
the Directors to estimate the future cash flows expected to arise
for the CGU and a suitable discount rate in order to calculate
present value. Where the actual future cash flows are less than
expected, a material impairment loss may arise.
Goodwill is subject to an annual impairment review
which is performed by comparing the recoverable amount of the CGU
to its carrying value. The recoverable amount is the higher of the
value in use and fair value to sell less costs.
Single enlarged
CGU
The assets directly relating to the Harpsden
acquisition, together with the in-place workforce and directly
attributable revenue and costs were previously separated in an
independent CGU within WH Ireland. The goodwill and intangibles
were previously allocated to the Harpsden CGU, these have now been
reallocated to the WM CGU. There no longer exists cash inflows for
Harpsden that are largely independent. Instead the cash inflows for
Harpsden are dependent on, and can be substituted with, cash
inflows in respect of the WM division as a whole. It is therefore
now the view of management that a change in CGUs is justified due
to the further integration of the Harpsden clients and operations
into the wider WM division.
Although the integration of Harpsden into the wider
WM division has occurred over time, there are a few factors that
have triggered a change in identification. The main factor is the
interdependence on cash inflows for Harpsden on the cash inflows of
the WM division. Other items judged to trigger this change in
identification include redistribution of Harpsden AUM across the
division, deregulation of the Harpsden entity with the FCA,
internal reporting of the branches within the WM division and the
use of group resources being shared across the division.
Investments in subsidiaries
Where an indicator of impairment exists, management
uses its judgement to assess the carrying value of the asset by
determining the fair value by independent assessment of the
carrying value of the business units. The carrying value of
investments in subsidiaries, prior to impairment, on 31 March 2024
was £26.4m (FY23: £26.4m) (see note 16).The market capitalisation
of WH Ireland Group Plc is £9.5m which is less than the £26.4m
holding of WHI Ltd and Harpsden Ltd together, which could indicate
an impairment.
At the year-ended 31 March 2024, the carrying values
of the investments in subsidiaries were consequently assessed for
indicators of impairment. The recoverable value of the two CGUs
were calculated using the Value in Use of WM and the sale price of
CM.
The value of investment in subsidiaries were
considered in the sum of two parts, for the two CGUs. The WM CGU
was valued by calculating its value in use (note 14). CM was
assessed with reference to the consideration for the disposal of
the division which occurred post year end (see note 33).
The sum of the two parts was £19.85m, resulting in
an impairment of £6.6m (note 16).
5. Segment information
The Group has two principal operating segments, WM
(WM) and CM (CM) and a number of central office costs that do not
fall into either of these operating segments. At 31 March 2024 both
of these operating segments met the criteria in IFRS 5 to be
classified as discontinued operations (see note 6 & 33).
This information has been disclosed to enable users of the
financial statements to see the breakdown of the groups result from
discontinued operations by segment.
WM offers investment management advice and services
to individuals and contains our Wealth Planning business, giving
advice on and acting as intermediary for a range of financial
products. CM provides corporate finance and corporate broking
advice and services to companies and acts as Nominated Adviser
(Nomad) to clients traded on the AIM and contains our Institutional
Sales and Research business, which carries out stockbroking
activities on behalf of companies as well as conducting research
into markets of interest to its clients.
Both divisions are located in the UK. Each
reportable segment has a segment manager who is directly
accountable to, and maintains regular contact with, the Chief
Executive Officer.
No customer represents more than ten percent of the
Group's revenue (FY23: nil).
The following tables represent revenue and cost
information for the Group's business segments. The key line items
below are not consistent with the statement of comprehensive
income.
Year ended 31 March 2024
|
WM
|
CM
|
Central
Office
|
Group
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Revenue
|
11,891
|
9,574
|
-
|
21,465
|
Direct costs
|
(9,628)
|
(9,448)
|
-
|
(19,076)
|
Contribution
|
2,263
|
126
|
-
|
2,389
|
Indirect costs*
|
(2,894)
|
(1,963)
|
-
|
(4,857)
|
Underlying loss before
tax
|
(631)
|
(1,837)
|
-
|
(2,468)
|
Amortisation of acquired brand and client
relationships
|
(273)
|
-
|
-
|
(273)
|
Release of deferred
consideration
|
-
|
-
|
160
|
160
|
Redundancy costs
|
(380)
|
(564)
|
-
|
(944)
|
Holiday Leave paid on termination
|
(43)
|
(83)
|
-
|
(126)
|
Project Costs
|
(865)
|
(527)
|
-
|
(1,392)
|
Onerous contracts
|
-
|
(447)
|
-
|
(447)
|
Client settlement
|
(152)
|
-
|
-
|
(152)
|
Investment losses
|
-
|
-
|
(583)
|
(583)
|
Payaway on investment
losses
|
-
|
274
|
-
|
274
|
Loss before tax
|
(2,344)
|
(3,184)
|
(423)
|
(5,951)
|
Tax
|
-
|
-
|
12
|
12
|
Loss for the year
|
(2,344)
|
(3,184)
|
(411)
|
(5,939)
|
*Includes £329k auditor's remuneration as
follows:
Audit of these financial statements £80k (FY23:
£60k)
Amounts payable to the principal auditors and their
associates in respect of:
o audit of financial
statements of subsidiaries pursuant to legislation £130k (FY23:
£115k)
o audit related
assurance services £59k (FY23: £50k)
o audit of financial
statements relating to prior year £60k (FY23: £50k)
Year ended 31 March 2024
|
WM
|
CM
|
Group
|
|
£'000
|
£'000
|
£'000
|
Statutory operating costs included
the following:
|
|
|
|
Amortisation
|
273
|
-
|
273
|
Depreciation
|
56
|
60
|
116
|
Depreciation from Right of Use assets
|
142
|
93
|
235
|
Year ended 31 March 2023
|
WM
|
CM
|
Central
Office
|
Group
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Revenue
|
14,443
|
12,245
|
-
|
26,688
|
Direct costs
|
(11,400)
|
(11,604)
|
-
|
(23,004)
|
Contribution
|
3,043
|
641
|
-
|
3,684
|
Indirect costs
|
(3,314)
|
(2,357)
|
-
|
(5,671)
|
Underlying profit / (loss) before
tax
|
(271)
|
(1,716)
|
-
|
(1,987)
|
|
Amortisation of acquired brand and
client relationships
|
(496)
|
-
|
-
|
(496)
|
|
Changes in fair value and finance
cost of deferred consideration
|
-
|
-
|
(173)
|
(173)
|
|
Other income
|
1,957
|
-
|
-
|
1,957
|
|
Investment losses
|
-
|
-
|
(2,683)
|
(2,683)
|
|
Payaway on investment
losses
|
-
|
1,559
|
-
|
1,559
|
|
Profit / (loss) before
tax
|
1,190
|
(157)
|
(2,856)
|
(1,823)
|
|
Tax
|
-
|
-
|
-
|
-
|
|
Profit / (loss) for the
year
|
1,190
|
(157)
|
(2,856)
|
(1,823)
|
|
The segment note has been restated to be consistent
with the current year presentation.
Year ended 31 March 2023
|
WM
|
CM
|
Group
|
|
£'000
|
£'000
|
£'000
|
Statutory operating costs included
the following:
|
|
|
|
Amortisation
|
496
|
-
|
496
|
Depreciation
|
141
|
90
|
231
|
Depreciation from Right of Use
assets
|
218
|
148
|
366
|
Segment assets and segment liabilities are reviewed
by the Chief Executive Officer based on the consolidated statement
of financial position. Accordingly, this information is replicated
in the Group Consolidated statement of financial position. As no
measure of assets or liabilities for individual segments is
reviewed regularly by the Chief Executive Officer, no disclosure of
total assets or liabilities has been made.
The accounting policies of the operating segments
are the same as those described in the summary of significant
accounting policies.
Revenue disaggregated by division and timing of
recognition below:
Year ended 31 March 2024
|
WM
|
CM
|
Group
|
|
£'000
|
£'000
|
£'000
|
Point in time
|
1,107
|
5,541
|
6,648
|
Over time
|
10,784
|
4,033
|
14,817
|
|
11,891
|
9,574
|
21,465
|
Year ended 31 March 2023
|
WM
|
CM
|
Group
|
|
£'000
|
£'000
|
£'000
|
Point in time
|
1,528
|
8,011
|
9,539
|
Over time
|
12,915
|
4,234
|
17,149
|
|
14,443
|
12,245
|
26,688
|
The following movement of contract liabilities was
recognised in the year:
|
As at 31
Mar 2023
|
Recognised in revenue
|
Amounts
deferred
|
As at 31
Mar 2024
|
Group
|
£'000
|
£'000
|
£'000
|
£'000
|
Contract liabilities
|
7
|
(7)
|
14
|
14
|
Contract liabilities relate to deferred recognition
of retainer fees invoices quarterly. Contract assets relate to
accrued management fee income and the decrease from £3m to £2.48m
at 31 March 2024 is linked to the decrease in WM fee income for the
period. Refer to note 20.
6. Discontinued operations and
assets & liabilities held for sale
During the year, management
entered into separate discussions to sell both divisions of the
group; WM and CM. This decision was taken in line with the Group's
strategy on returning the business to sustainable profitability.
Consequently, all non-current and associated current assets and
liabilities were classified as a disposal group. WM has been judged
to be held for sale from 31 October 2023 and CM from 15 February
2024. Assets and Liabilities held for sale have been allocated to
the associated disposal groups on these dates. Measurement of the
disposal group's assets is based on the lower of their carrying
amount and fair value less costs to sell.
Financial performance information
|
|
Year ended
|
Year
ended
|
|
|
31 Mar
2024
|
31 Mar
2023
|
|
Note
|
£'000
|
£'000
|
Revenue
|
|
21,465
|
26,688
|
Administrative expenses
|
|
(26,665)
|
(25,416)
|
Expected credit loss
|
20
|
(328)
|
(239)
|
Operating
loss
|
|
(5,528)
|
1,033
|
Taxation
|
10
|
-
|
-
|
Post-tax (loss)/ profit from discontinuing
operations
|
|
(5,528)
|
1,033
|
The carrying amounts of assets and
liabilities in the disposal group may be analysed as
follows:
Assets and liabilities of disposal group classified as held
for sale
|
|
|
|
|
|
|
|
|
|
Year ended 31 Mar 2024
|
|
WM
|
CM
|
Total
|
Assets classified as held for
sale
|
Note
|
£'000
|
£'000
|
£'000
|
Intangible assets
|
15
|
3,490
|
-
|
3,490
|
Goodwill
|
14
|
3,539
|
-
|
3,539
|
Property, plant and
equipment
|
13
|
255
|
214
|
469
|
Investments - warrants
|
17
|
-
|
95
|
95
|
Right of use asset
|
18
|
378
|
23
|
401
|
Total assets held for sale
|
|
7,662
|
332
|
7,994
|
|
|
|
|
|
|
|
|
|
|
Year ended 31 Mar 2024
|
|
WM
|
CM
|
Total
|
Liabilities directly associated
with assets classified as held for sale
|
Note
|
£'000
|
£'000
|
£'000
|
Lease liability
|
18
|
(272)
|
(21)
|
(293)
|
Total liabilities held for
sale
|
|
(272)
|
(21)
|
(293)
|
|
Year ended
31-Mar-24
|
Year
ended 31-Mar-23
|
|
|
£'000
|
£'000
|
|
Cash flows from operating
activities
|
(5,306)
|
1,305
|
|
Cash flows from investing
activities
|
(16)
|
(475)
|
|
Cash flows from financing
activities
|
(340)
|
(483)
|
|
Total cash movement from
discontinued activities
|
(5,662)
|
347
|
|
|
|
|
|
|
|
|
|
7. Employee benefit
expense
Non-salaried staff are commission-only brokers and
therefore do not receive a salary.
|
Year ended
|
Year
ended
|
|
31 Mar
2024
|
31 Mar
2023
|
Group
|
£'000
|
£'000
|
Wages and salaries
|
10,970
|
11,970
|
Bonuses
|
618
|
1,537
|
Social security costs
|
1,442
|
1,734
|
Other pension costs
|
469
|
539
|
|
13,499
|
15,780
|
Non salaried staff
|
1,592
|
605
|
Charge for share options granted
to employees (note 30)
|
338
|
359
|
|
15,429
|
16,744
|
|
|
|
|
Year ended
|
Year
ended
|
|
31 Mar
2024
|
31 Mar
2023
|
Company
|
£'000
|
£'000
|
Wages and salaries
|
249
|
207
|
|
|
|
|
|
|
The average number of persons (including Directors) employed
during the year was:
|
|
|
|
|
|
Year ended
|
Year
ended
|
Group
|
31 Mar
2024
|
31 Mar
2023
|
Executive and senior
management
|
6
|
6
|
CM
|
36
|
50
|
WM
|
68
|
74
|
Support staff
|
20
|
30
|
Salaried staff
|
130
|
160
|
Non salaried staff
|
3
|
3
|
Total
|
133
|
163
|
|
|
|
|
Year ended
|
Year
ended
|
Company
|
31 Mar
2024
|
31 Mar
2023
|
Executive and senior
management
|
3
|
4
|
The total amount paid to Directors in the period,
including social security costs was £0.8m (FY23: £0.9m). Full
details of Directors' remuneration, including that of the highest
paid Director, are disclosed in the Remuneration Report of the
financial statements.
8. Finance income and expense
|
Year ended
|
Year
ended
|
|
31 Mar
2024
|
31 Mar
2023
|
Group
|
£'000
|
£'000
|
Bank interest
receivable
|
12
|
10
|
Other interest
|
-
|
-
|
Finance income
|
12
|
10
|
|
|
-
|
|
|
|
Interest payable on lease
liabilities classified within result from discontinued
operations
|
21
|
51
|
Release of deferred
consideration (see note 24)
|
(160)
|
173
|
Finance expense
|
(139)
|
224
|
9. Other income
|
Year ended
|
Year
ended
|
|
31 Mar
2024
|
31 Mar
2023
|
Group
|
£'000
|
£'000
|
VAT refund
|
-
|
2,175
|
Total other income
|
-
|
2,175
|
During the previous year the Group received a refund
of £2.2m from HMRC. This was following confirmation from HMRC that
the supply of certain Group services were exempt from VAT during
the period from 2017 to 2022.
10. Taxation
|
Year ended
|
Year
ended
|
|
31 Mar
2024
|
31 Mar
2023
|
Group
|
£'000
|
£'000
*Restated
|
Current tax expense:
|
|
|
United Kingdom corporation tax at
25% (FY23: 19%)
|
-
|
-
|
Adjustment in respect of prior
year
|
(12)
|
-
|
Total current tax
|
(12)
|
-
|
|
|
|
Deferred tax credit (note
19):
|
|
|
Current year
|
-
|
-
|
Effect of change in tax
rate
|
-
|
-
|
Total deferred tax
|
-
|
-
|
Total tax
|
(12)
|
-
|
*The 2023 taxation note has been restated to reflect
the recognition of a deferred tax asset to offset the deferred tax
liability. Refer to Note 19 for further details.
The tax credit for the year and the amount calculated
by applying the standard United Kingdom corporation tax rate of 25%
(FY23: 19%) to profit before tax can be reconciled as follows:
|
Year ended
|
Year
ended
|
|
31 Mar
2024
|
31 Mar
2023
|
Group
|
£'000
|
£'000
|
Loss before tax
|
(5,951)
|
(1,823)
|
Tax expense using the United
Kingdom corporation tax rate of 25% (FY23: 19%)
|
(1,488)
|
(346)
|
Other expenses not tax
deductible
|
313
|
334
|
Income not chargeable to
tax
|
-
|
(11)
|
Movement in unrecognised deferred
tax
|
1,163
|
9
|
Other amounts
|
-
|
14
|
Total tax (credit) /
charge
|
(12)
|
-
|
11. Dividend
No dividend is proposed in respect of 2024 (FY23:
none).
12. Earnings per share
(EPS)
Basic EPS is calculated by dividing the profit or
loss attributable to equity holders of the Company by the weighted
average number of ordinary shares in issue during the year,
excluding ordinary shares purchased by the Company (note 28).
Diluted EPS is the basic EPS, adjusted for the
effect of the conversion into fully paid shares of the weighted
average number of all employee share options outstanding. In a year
when the Company presents positive earnings attributable to
ordinary shareholders, anti-dilutive options represent options
issued where the exercise price is greater than the average market
price for the period.
|
Year ended
|
Year
ended
|
|
31 Mar
2024
|
31 Mar
2023
|
Group
|
|
|
Weighted average number of shares
in issue during the period
|
175,718
|
59,172
|
Effect of dilutive share
options
|
-
|
-
|
(thousands)
|
|
|
|
175,718
|
59,172
|
|
|
|
Total
|
|
|
Post-tax loss from continuing
operations (£'000)
|
(411)
|
(2,856)
|
(Loss)/profit from discontinuing
operations incl. tax (£'000)
|
(5,528)
|
1,033
|
Earning per share - basic and diluted
|
|
|
From continuing
operations
|
(0.23p)
|
(4.83p)
|
From discontinuing
operations
|
(3.15p)
|
1.75p
|
Total
|
(3.38p)
|
(3.08p)
|
Reconciliations of the earnings and weighted average
number of shares used in the calculations are set out below:
*The 2023 Earnings per share note has been restated to
reflect the recognition of a deferred tax asset to offset the
deferred tax liability. Refer to Note 19 for further details.
13. Property, plant and
equipment
|
Group
|
|
Company
|
|
Computers,
|
|
Computers,
|
|
fixtures and
fittings
|
|
fixtures and
fittings
|
|
£'000
|
|
£'000
|
Cost
|
|
|
|
At 31 March 2022
|
5,748
|
|
37
|
Additions
|
475
|
|
-
|
Disposal
|
-
|
|
(4)
|
At 31 March 2023
|
6,223
|
|
33
|
Additions
|
16
|
|
-
|
Transfer to asset held for sale
|
(6,239)
|
|
-
|
At 31 March 2024
|
-
|
|
33
|
|
|
|
|
Depreciation and impairment
|
|
|
|
At 31 March 2022
|
5,423
|
|
33
|
Depreciation charge
|
231
|
|
-
|
At 31 March 2023
|
5,654
|
|
33
|
Depreciation charge
|
116
|
|
-
|
Transfer to asset held for sale
|
(5,770)
|
|
-
|
At 31 March 2024
|
-
|
|
33
|
|
|
|
|
Net book values
|
|
|
|
At 31 March 2024
|
-
|
|
-
|
At 31 March 2023
|
569
|
|
-
|
Property, plant and equipment were transferred to
the WM and CM disposal groups on 31 October 2023 and 15 February
2024 respectively.
Included in the above, are software costs
capitalised in the year with a net book value at 31 March 2024 of
£9k (FY23: £116k).
14. Goodwill
Goodwill acquired in a business combination is
allocated to a cash generating unit (CGU) that will benefit from
that business combination. As explained in note 4, the goodwill is
now attributed to the WM CGU.
The carrying amount of goodwill acquired in the
acquisition of Harpsden WM is set out below:
|
Year ended
|
Year
ended
|
|
31 Mar
2024
|
31 Mar
2023
|
Group
|
£'000
|
£'000
|
Beginning of year
|
3,539
|
3,539
|
Transfer to asset held for sale
|
(3,539)
|
-
|
End of year
|
-
|
3,539
|
Goodwill is assessed annually for impairment and the
recoverability has been assessed at 31 March 2024 by comparing the
carrying value of the CGU to which the goodwill is allocated
against its recoverable amount. The recoverable amount is the
higher of the CGU's fair value less cost to sell and the value in
use. The value in use has been calculated using pre-tax discounted
cash flow projections based on the most recent budgets and
forecasts approved by the Board of Directors.
The projections cover a five-year period and a
terminal multiple has been applied to the cash-flows extrapolating
the projections consistent with the assumed indefinite useful life
of the goodwill. The projections are based on a four-year forecast
that has been approved by the board, with the fifth year being
extrapolated using the trend in the forecast.
The newly enlarged WM CGU recoverable amount was
calculated as £18.0m, with a headroom of £10m which indicates that
there is no impairment. The main underlying assumptions used in the
calculations are the pre-tax discount rate, the short-term growth
in revenue and expenditure and the long-term growth rate to
perpetuity. The revenue growth used in the cash flow forecast is
based on the AUM forecasts multiplied by the relevant yields. AUM
forecasted growth ranges from 0.0% to 8.2%. Cash outflows are
forecasted individually, in an absence of specific detail these
costs are set to increase by 5% in line with inflation. A pre-tax
discount rate of 17.0% has been used. This is based on the Group's
assessment of the risk-free rate of interest and specific risks
relating to the division. A 2% long-term growth rate has been
applied, which is prudent when compared against the growth rates
used in the forecast calculations for the first five years.
Sensitivity analysis has been performed and no
impairment would arise if the following scenarios occurred:
· A fall in AUM in FY25
to FY29 of 12% each year would result in a break-even position
· Costs for the entire
business applying to the WM CGU - if all forecasted costs were
applied to the WM CGU, the headroom would reduce to £4m. Still,
this would not result in an impairment of the CGU
This amount was transferred to the WM disposal group
on 31 October 2023.
15. Intangible assets
Client relationships arise when the group acquires a
broker business with an existing client base. The assets below
represent the fair value of future benefits arising from these
client relationships. Amortisation of client relationships is
charged to administrative expenses in note 6 on a straight-line
basis over the estimated useful lives (2 to 12 years). No
impairment indicators were present for the acquired client
relationship contracts.
|
Client
|
|
|
|
relationships
|
Brand
|
Total
|
Group
|
£'000
|
£'000
|
£'000
|
Cost
|
|
|
|
At 31 March 2022
|
8,731
|
75
|
8,806
|
Additions
|
-
|
-
|
-
|
At 31 March 2023
|
8,731
|
75
|
8,806
|
Additions
|
-
|
-
|
-
|
Transfer to asset held for sale
|
(8,731)
|
(75)
|
(8,806)
|
At 31 March 2024
|
-
|
-
|
-
|
|
|
|
|
Amortisation
|
|
|
|
At 31 March 2022
|
4,500
|
47
|
4,547
|
Charge for the year
|
468
|
28
|
496
|
At 31 March 2023
|
4,968
|
75
|
5,043
|
Charge for the year
|
273
|
-
|
273
|
Transfer to asset held for sale
|
(5,241)
|
(75)
|
(5,316)
|
At 31 March 2024
|
-
|
-
|
-
|
|
|
|
|
Net book values
|
|
|
|
At 31 March 2024
|
-
|
-
|
-
|
At 31 March 2023
|
3,763
|
-
|
3,763
|
During the year ended 31 March 2021, the group
acquired client relationships totalling £4.2m as part of the
Harpsden acquisition and at the year ending 31 March 2024 the net
book value was £3.25m (FY23: £3.37m) and remaining useful economic
life of 7 years (FY23: 8 years). An intangible asset was also
recognised representing the Harpsden brand totalling £75k and at
the year ending 31 March 2024 the net book value was fully
amortised.
An intangible asset was recognised relating to the
client relationships brought in by Robert Race when he joined the
group. At the year ended 31 March 2024 the net book value was £244k
(FY23: £367k) and remaining useful economic life of 2 years (FY23:
3 years). The Harpsden and Robert Race client relationships total
net book value comes to £3.49m.
These were transferred to the WM disposal group on
31 October 2023.
The company did not have any intangible assets
either at 31 March 2024 or 31 March 2023.
16. Subsidiaries
|
|
Year ended
|
Year
ended
|
|
Note
|
31 Mar
2024
|
31 Mar
2032
|
Company
|
|
£'000
|
£'000
|
Beginning of year
|
|
26,448
|
26,448
|
Impairment
|
4
|
(6,600)
|
-
|
End of year
|
|
19,848
|
26,448
|
Investments in subsidiaries are stated at cost less
impairment.
The Company's subsidiaries, all of which are
included in the consolidated financial statements, are presented
below:
Subsidiary
|
Country of
incorporation
|
Principal
activity
|
Class of
shares
|
Proportion held by
Group
|
Proportion held by
Company
|
WH Ireland Limited
|
England & Wales
|
WM
and CM
|
Ordinary
|
100%
|
100%
|
Harpsden WM Limited
|
England & Wales
|
WM
|
Ordinary
|
100%
|
100%
|
WH Ireland (Financial Services)
Limited
|
England & Wales
|
Dormant
|
Ordinary
|
100%
|
-
|
Readycount Limited
|
England & Wales
|
Dormant
|
Ordinary
|
100%
|
100%
|
Stockholm Investments
Limited
|
England & Wales
|
Dormant
|
Ordinary
|
100%
|
100%
|
ARE Business and Professional
Limited
|
England & Wales
|
Dormant
|
Ordinary
|
100%
|
-
|
SRS Business and Professional
Limited
|
England & Wales
|
Dormant
|
Ordinary
|
100%
|
-
|
WH Ireland Nominees
Limited
|
England & Wales
|
Nominee
|
Ordinary
|
100%
|
-
|
WH Ireland Trustee
Limited
|
England & Wales
|
Trustee
|
Ordinary
|
100%
|
-
|
Fitel Nominees Limited
|
England & Wales
|
Nominee
|
Ordinary
|
100%
|
-
|
The registered office of all companies listed above
is 24 Martin Lane, London, EC4R 0DR.
The following dormant subsidiaries are guaranteed by
the Company and therefore take advantage of the Companies Act
(2006) in obtaining exemption from an individual audit:
Subsidiary
|
Country of
incorporation
|
Company registration
number
|
WH Ireland (Financial Services)
Limited
|
England & Wales
|
4279349
|
Readycount Limited
|
England & Wales
|
3164863
|
Stockholm Investments
Limited
|
England & Wales
|
4215675
|
ARE Business and Professional
Limited
|
England & Wales
|
3681185
|
SRS Business and Professional
Limited
|
England & Wales
|
4238969
|
WH Ireland Nominees
Limited
|
England & Wales
|
2908691
|
WH Ireland Trustee
Limited
|
England & Wales
|
3559373
|
Fitel Nominees Limited
|
England & Wales
|
1401140
|
17. Investments
Group
|
|
|
|
|
Quoted
|
Warrants
|
Total
|
Other financial assets at fair value through profit or
loss
|
£'000
|
£'000
|
£'000
|
At 31 March 2022
|
1
|
2,964
|
2,965
|
Additions
|
-
|
286
|
286
|
Fair value loss
|
-
|
(2,060)
|
(2,060)
|
Disposals
|
(1)
|
(370)
|
(371)
|
At 31 March 2023
|
-
|
820
|
820
|
Additions
|
-
|
184
|
184
|
Fair value loss
|
-
|
(597)
|
(597)
|
Disposals
|
-
|
(312)
|
(312)
|
Transfer to asset held for sale
|
-
|
(95)
|
(95)
|
At 31 March 2024
|
-
|
-
|
-
|
|
|
|
|
Total investments at 31 March 2024
|
-
|
-
|
-
|
Total investments at 31 March
2023
|
-
|
820
|
820
|
Financial assets at fair value through profit or
loss include equity investments other than those in subsidiary
undertakings. These are measured at fair value with fair value
gains and losses recognised through profit and loss.
Other investments, in the main, comprise financial
assets designated as fair value through profit or loss and include
warrants and equity investments. These were transferred to the CM
disposal group on 15 February 2024.
Warrants may be received during the ordinary course
of business and are designated as fair value through profit or
loss. There is no cash consideration associated with the
acquisition.
Fair value, in the case of quoted investments,
represents the bid price at the reporting year-end date. In the
case of unquoted investments, the fair value is estimated by
reference to recent arm's length transactions. The fair value of
warrants is estimated using established valuation models.
The fair value of the warrants was determined using
the Black Scholes model and grouped within level 3 with fair value
measurements derived from formal valuation techniques (see note
25). The key inputs into this calculation are the share price as at
31 March 2024, exercise price, risk free interest rate and
volatility which is based on the share price movements during the
same length as the remaining time of exercise.
|
|
Year ended
|
Year
ended
|
|
|
31 Mar
2024
|
31 Mar
2023
|
Net loss on investments
|
Note
|
£'000
|
£'000
|
Fair value loss on
warrants
|
|
(597)
|
(2,060)
|
Fair value gain / (loss) on
investments
|
21
|
14
|
(623)
|
Total net loss on investments
|
|
(583)
|
(2,683)
|
18. Right of use asset and lease
liability
|
Leasehold
Properties
|
|
£'000
|
Cost
|
|
At 31 March 2022
|
2,667
|
Additions
|
445
|
Disposals
|
(1,185)
|
Deferred rent release
|
125
|
At 31 March 2023
|
2,052
|
Transferred to asset held for sale
|
(2,052)
|
At 31 March 2024
|
-
|
|
|
Depreciation and impairment
|
|
At 31 March 2022
|
1,499
|
Charge for the year
|
366
|
Disposal
|
(448)
|
At 31 March 2023
|
1,417
|
Charge for the year
|
235
|
Transfer to asset held for sale
|
(1,652)
|
At 31 March 2024
|
-
|
|
|
Net book values
|
|
At 31 March 2024
|
-
|
At 31 March 2023
|
635
|
Maturity of discounted lease payments in
relation to non-cancellable leases
The table below represents the minimum lease
payments in relation to non-cancellable leases where the group is a
lessee:
|
Group
|
|
Payable
within 1 year
|
Payable
in 2 to 5 years
|
Payable
after more than 5 years
|
Total contractual
payments
|
Group
|
£'000
|
£'000
|
£'000
|
£'000
|
2024
|
97
|
196
|
-
|
293
|
2023
|
319
|
281
|
12
|
612
|
The leases were transferred to the WM and CM
disposal groups on 31 October 2023 and 15 February 2024
respectively.
The following represents the lease expense in
relation to leases which is recognised in the statement of
comprehensive income:
|
Year ended
|
Year
ended
|
|
31 Mar
2024
|
31 Mar
2023
|
Group
|
£'000
|
£'000
|
Depreciation of right of use
asset
|
235
|
366
|
Deferred rent release
|
-
|
(125)
|
Interest charge
|
21
|
51
|
Total charge
|
256
|
292
|
Nature of leases
The Group leases a number of properties in the
jurisdictions it operates.
These leases are usually for a fixed term although
the Group sometimes negotiates break clauses in its leases. On a
case-by-case basis, the Group will consider whether the absence of
a break clause would expose the group to excessive risk. Typically
factors considered in deciding to negotiate a break clause
include:
· the length of the
lease term;
· the economic stability
of the environment in which the property is located; and
· whether the location
represents a new area of operations for the Group
As at 31 March 2024, the carrying amounts of the
lease liabilities are not reduced by the amounts that would not be
paid as a result of exercising the break clauses because the Group
does not anticipate exercising its rights to the break clauses.
The total cash outflow for leases, including
short-term leases, in the year ending 31 March 2024 was £340k
(FY23: £483k)
Payments associated with short-term leases and all
leases of low-value assets are recognised on a straight-line basis
in administrative expenses in note 6. Short-term leases are leases
with a lease term of 12 months or less without a purchase option,
short term leases recorded as an expense during the year was
£115k.
The Company did not have any right of use assets or
lease liabilities either at 31 March 2024 or 31 March 2023.
19. Deferred tax assets and
liabilities
Deferred tax is provided for temporary differences,
at the reporting year-end date, between the tax bases of assets and
liabilities and their carrying amounts for financial reporting
purposes using a tax rate of 25% (FY23: 19%). A deferred tax asset
is recognised for all deductible temporary differences and
unutilised tax losses only to the extent that it is probable that
future taxable profits will be available against which the assets
can be utilised. Deferred tax assets are reduced to the extent that
it is no longer probable that the related tax benefit will be
realised.
The deferred tax liability balance has been restated
during the year . There is a net nil deferred tax position as at 31
March 2024 and 31 March 2023.
Year ended 31 March 2024
|
Asset
£'000
|
Liability
£'000
|
Net
£'000
|
Business Combinations
|
-
|
(596)
|
(596)
|
Trading losses carried
forward
|
596
|
-
|
596
|
Deferred tax asset/ (liability)
|
596
|
(596)
|
-
|
Set off
|
(596)
|
596
|
-
|
Net deferred tax asset/
(liability)
|
-
|
-
|
-
|
|
|
|
|
Year ended 31 March 2023
|
Asset
£'000
(restated)
|
Liability
£'000
|
Net
£'000
|
Business Combinations
|
-
|
(663)
|
(663)
|
Trading losses carried
forward
|
663
|
-
|
663
|
Deferred tax asset/ (liability)
|
663
|
(663)
|
-
|
Set off
|
(663)
|
663
|
-
|
Net deferred tax asset/
(liability)
|
-
|
-
|
-
|
The carrying amount of the deferred tax asset is reviewed at each
reporting date and is only recognised to the extent that it is
probable that future taxable profits of the Group will allow the
asset to be recovered.
The unrecognised tax losses and fixed asset timing
differences amount to £18.3m (FY23: £17.1m). No deferred tax has
been recognised in respect of these losses due to the uncertainty
over the timing of future profits.
The change in deferred tax assets and liabilities
during the year was as follows:
|
|
|
|
|
Asset
£'000
|
Liability
£'000
|
Net
£'000
|
|
Balance as at 1 April
2022
|
542
|
(542)
|
-
|
|
Released to Consolidated statement
of comprehensive income
|
121
|
(121)
|
-
|
|
Balance as at a 31 March
2023
|
663
|
(663)
|
-
|
|
|
|
|
|
|
Released to Consolidated statement
of comprehensive income
|
(67)
|
67
|
-
|
|
Balance as at 31 March
2024
|
596
|
(596)
|
-
|
|
The Company had no deferred tax balances either at
31 March 2024 or 31 March 2023.
Restatement of
deferred tax asset
The Group has a deferred tax liability in relation
to temporary differences on intangible assets recognised as part of
acquisition accounting for business combinations in the Group's
consolidated financial statements. Such intangible assets are not
permitted to be recognised in the acquiree's separate financial
statements.
Upon acquisition accounting, the Group did not
reassess whether an additional deferred tax asset could have been
recognised to the extent of the additional deferred tax liability
that was recognised in the consolidated financial statements.
There has previously been a diversity of practice in
relation to the accounting treatment for the recognition of
deferred tax assets on business combinations in accordance with IAS
12. There has been solidification following publication of recent
reviews, which have clarified the position, resulting in the
recognition of a deferred tax asset on consolidation to the extent
the Group has unused tax losses available, to offset the deferred
tax liability.
This is because the taxable temporary differences
associated with the intangible assets relates to the same tax
authority (UK) as the Group as such the asset meets the criteria
for recognition. In addition, the offset criteria of IAS 12 are
also met and therefore the deferred tax amounts are presented net
in the consolidated statement of financial position. The additional
deferred tax asset recognised for tax attributes within the
existing Group is credited to the consolidated statement of
comprehensive income.
This change in accounting treatment has been applied
retrospectively by restating each of the affected financial
statement line items as follows. A third consolidated statement of
financial position has been presented as of 31 March 2022 and the
impact of the adjustment is below.
Consolidated
statement of financial position:
|
2022
Prior to adjustment
£'000
|
Adjustment
£'000
|
2022
Restated
£'000
|
Deferred tax asset/(liability)
|
|
|
|
Deferred tax
|
(542)
|
542
|
-
|
Equity
|
|
|
|
Retained earnings
|
(6,789)
|
542
|
(6,247)
|
|
2023
Prior to adjustment
£'000
|
Adjustment
£'000
|
2023
Restated
£'000
|
Deferred tax asset/ (liability)
|
|
|
|
Deferred tax
|
(663)
|
663
|
-
|
Equity
|
|
|
|
Retained earnings
|
(8,374)
|
663
|
(7,711)
|
The Deferred tax as at 31 March 2022 of £542k above
represents the net of the non-current deferred tax asset and
current deferred tax liability that were previously presented gross
in the consolidated statement of financial position at 31 March
2022.
Consolidated
statement of changes in equity:
|
2022
Prior to adjustment
£'000
|
Adjustment
£'000
|
2022
Restated
£'000
|
Equity
|
|
|
|
Retained earnings
|
(6,789)
|
542
|
(6,247)
|
|
2023
Prior to adjustment
£'000
|
Adjustment
£'000
|
2023
Restated
£'000
|
Equity
|
|
|
|
Retained earnings
|
(8,374)
|
663
|
(7,711)
|
Consolidated
statement of profit or loss and other comprehensive
income:
|
2023
Prior to adjustment
£'000
|
Adjustment
£'000
|
2023
Restated
£'000
|
Income tax charge/
(credit)
|
(121)
|
(121)
|
-
|
Total Profit/ (Loss) for the
year
|
(1,944)
|
(121)
|
(1,823)
|
20. Trade and other
receivables
|
Group
|
Company
|
|
31 Mar
2024
|
31 Mar
2023
|
31 Mar
2024
|
31 Mar
2023
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Non-current assets
|
|
|
|
|
Amounts owed from Group
companies
|
-
|
-
|
4,676
|
|
Current assets
|
|
|
|
|
Trade receivables
|
508
|
643
|
-
|
-
|
Other receivables
|
874
|
528
|
26
|
14
|
Contract assets
|
2,481
|
3,008
|
-
|
-
|
Prepayments
|
1,235
|
1,265
|
18
|
15
|
|
5,098
|
5,444
|
44
|
29
|
The carrying value of trade and other receivable
balances are denominated fully in British pounds (FY23: 100%).
Contract assets relates to management fee accruals.
Management fees are accrued on a monthly basis and reconciled to
fees collected quarterly. Consideration to IFRS 9 has been made and
it has been determined that there is a low probability of default
and therefore the expected credit loss is not material.
The impact of applying IFRS 9 to intercompany
balances for the Company has been considered and probability of
default was assessed and consequently, it was determined that the
expected credit loss is not material.
Fees and charges owed by clients are generally
considered to be past due where they remain unpaid five working
days after the relevant billing date. At 31 March 2024, trade
receivables (net of provisions for impairment and doubtful debts)
comprised of the following:
|
Group
|
Company
|
|
31 Mar
2024
|
31 Mar
2023
|
31 Mar
2024
|
31 Mar
2023
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Not past due
|
61
|
17
|
-
|
-
|
Up to 5 days due
|
-
|
-
|
-
|
-
|
from 6 to 15 days past
due
|
12
|
-
|
-
|
-
|
From 16 to 30 days past
due
|
6
|
-
|
-
|
-
|
From 31 to 45 days past
due
|
43
|
467
|
-
|
-
|
More than 45 days past
due
|
386
|
159
|
-
|
-
|
|
508
|
643
|
-
|
-
|
Trade receivables are largely amounts due from
retainer clients, who are invoiced on a quarterly basis in advance.
The Group's payment terms are set out in each client's engagement
letter (with a maximum of 30 days). Consequently, these receivables
have no significant financing component and the Group have applied
the simplified approach in line with IFRS 9. Calculation of loss
allowances are measured at an amount equal to lifetime expected
credit losses (ECLs). The approach taken by the Group in arriving
at the expected credit loss is as follows:
Step 1: The Group have determined the appropriate
brackets by grouping each trade receivables based on the ageing
structure.
Step 2: Having determined the appropriate groupings,
a historical loss rate (adjusted for forward looking information)
was calculated for each age bracket by reviewing the pattern of
payment of trade receivables over the past 12 months.
Step 3: This historical loss rate (adjusted for
forward looking information) has been applied to each ageing
bracket of trade receivables as at the balance sheet date to arrive
at an expected credit loss for each grouping. All trade receivables
over 365 days have a 100% historical loss rate loss applied to
them.
Based on the above, the group recognised an expected
credit loss of £328k (FY23: £239k expected credit loss).
The maximum exposure to credit risk, before any
collateral held as security, is the carrying value of each class of
receivable set out above.
The Directors consider that the carrying amounts of
trade and other receivables approximate their fair value.
Movements in impairment provisions were as
follows:
|
Group
|
Company
|
|
31 Mar
2024
|
31 Mar
2023
|
31 Mar
2024
|
31 Mar
2023
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Opening balance
|
248
|
502
|
-
|
-
|
Amount released from provision due
to recovery
|
(66)
|
(25)
|
-
|
-
|
Amounts written off, previously
fully provided
|
(121)
|
(493)
|
-
|
-
|
Amount charged to the statement of
comprehensive income
|
394
|
264
|
-
|
-
|
Closing balance
|
455
|
248
|
-
|
-
|
21. Other investments
|
Group
|
Company
|
|
31 Mar
2024
|
31 Mar
2023
|
|
31 Mar
2024
|
31 Mar
2023
|
|
£'000
|
£'000
|
|
£'000
|
£'000
|
Current asset
investment
|
671
|
922
|
|
-
|
-
|
Restricted cash
|
873
|
1,127
|
|
-
|
-
|
Total
|
1,544
|
2,049
|
|
-
|
-
|
Current asset investments represent short-term
principal positions in the form of listed and unquoted investments
which are held at market value.
Included in current asset investments are unquoted
investments totalling a value of £nil (FY23: £nil).
Restricted cash represents monies held by the Group
which have some restrictions on their conversion to cash. The cash
is held by an external broker which has restrictions on cash in
order to comply with margin requirements.
Included in net loss on investments, in the
Consolidated statement of comprehensive income is the fair value
gain and the sale of investments. Further details can be found in
note 17.
22. Cash and cash
equivalents
|
Group
|
Company
|
|
31 Mar
2024
|
31 Mar
2023
|
31 Mar
2024
|
31 Mar
2023
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Cash and cash
equivalents
|
4,902
|
4,234
|
-
|
-
|
For the purposes of the cash flow statement, cash
and cash equivalents comprise cash in hand and deposits with banks
and financial institutions with a maturity of up to three
months.
Cash and cash equivalents represent the Group's and
the Company's money and money held for settlement of outstanding
transactions.
Money held on behalf of clients is not included in
cash and cash equivalents on the statement of financial position.
Client money at 31 March 2024 for the Group was £137k (FY23:
£301k). There is no client money held in the Company (FY23:
£nil).
23. Trade and other
payables
|
Group
|
Company
|
|
31 Mar
2024
|
31 Mar
2023
|
31 Mar
2024
|
31 Mar
2023
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Trade payables
|
1,210
|
1,148
|
226
|
12
|
Amounts due to Group
companies
|
-
|
-
|
312
|
790
|
Other payables
|
192
|
89
|
-
|
-
|
Tax and social security
|
289
|
588
|
-
|
-
|
Contract liabilities
|
14
|
7
|
-
|
-
|
Accruals
|
1,527
|
2,181
|
212
|
334
|
|
3,232
|
4,013
|
750
|
1,136
|
The Directors consider that the carrying
amounts of trade and other payables approximate their fair
value.
Deferred income relates to retainer fees
invoiced in advance and spread over the length of the period,
typically quarterly. The balance at year-end was fully recognised
in the following financial year.
Amounts due to Group companies are unsecured,
interest free and repayable on demand.
24. Provisions
|
Group
|
Company
|
|
Deferred
consi-
deration
|
Provision for onerous contracts
|
Other
provision
|
£'000
|
Deferred
consi-
deration
|
Other
provision
|
£'000
|
At 31 March 2022
|
2,412
|
-
|
-
|
2,412
|
2,412
|
-
|
2,412
|
Charged to Statement of
Comprehensive Income
|
173
|
-
|
-
|
173
|
173
|
-
|
173
|
Paid during the year
|
(464)
|
-
|
-
|
(464)
|
(464)
|
-
|
(464)
|
At 31 March 2023
|
2,121
|
-
|
-
|
2,121
|
2,121
|
-
|
2,121
|
(Credited)/charged to Statement of
Comprehensive Income
|
(160)
|
447
|
-
|
287
|
(160)
|
-
|
287
|
Reclassification
|
(354)
|
-
|
354
|
-
|
(354)
|
354
|
-
|
Paid during the year
|
(78)
|
-
|
-
|
(78)
|
(78)
|
-
|
(78)
|
Settled during the year via share
issue
|
(654)
|
-
|
-
|
(654)
|
(654)
|
-
|
(654)
|
At 31 March 2024
|
875
|
447
|
354
|
1,676
|
875
|
354
|
1,229
|
Provisions of £1,676k (2023: £2,121k) are included
in current liabilities.
Deferred consideration relates to the acquisition of
Harpsden and the maximum amounts payable over a two-year period.
The following assumptions were made: revenue growth of 2%,
attrition rate of 3% for larger clients and 10% for smaller
clients, discount rate of 13.5%.
During the year £78k was paid to former shareholders
of Harpsden WM Limited (Harpsden) in relation to the deferred
consideration due. A further settlement to the former shareholders
of Harpsden of £654k was made by way of share issue. The group
reached an agreement with the former shareholders on a final
payment of £875k that has been paid after the year end. Following
the settlement agreement, the deferred consideration provision was
reduced so that the carrying value at 31 March 2024 reflects the
final agreed settlement amount of £875k. This resulted in £160k
being released and credited to profit or loss. The remaining excess
provision of £354k has been retained by the Group and reclassified
to other provisions on account of potential future claims that may
arise.
As part of the sale of the CM division there are
existing contracts that run until December 2024. These services
will not be used by the business going forward so are included in
the discontinued operations for CM. These are onerous contracts as
the Group is locked into them and are not transferred to the
buyer.
The other provision is for a potential liability in
relation to the deferred consideration. There is uncertainty around
the timing of this liability as well as the amount. This may fall
due within one year, as such this liability is shown as
current.
25. Financial risk
management
The fair value of all the Group's and the Company's
financial assets and liabilities approximated to their carrying
value at the reporting year-end date. The carrying amount of
non-current financial instruments, including floating interest rate
borrowing, are not significantly different from the fair value of
these instruments based on discounted cash flows. The significant
methods and assumptions used in estimating fair values of financial
instruments are summarised below:
Financial assets at fair value through profit or loss
Financial assets at fair value through profit or
loss include equity investments, other than those in subsidiary
undertakings. In the case of listed investments, the fair value
represents the quoted bid price at the reporting period end date.
The fair value of unlisted investments is estimated by reference to
recent arm's length transactions.
Other investments
Other investments include warrants and equity
investments, categorised as fair value through profit or loss. In
the case of listed investments, the fair value represents the
quoted bid price at the reporting year-end date. The fair value of
unlisted investments is estimated by reference to recent arm's
length transactions. In the case of warrants, the fair value is
estimated using established valuation models.
Trade receivables and payables
The carrying value less impairment provision of
trade receivables and payables is assumed to approximate to their
fair values due to their short-term nature.
Borrowings
Borrowings are measured at amortised cost using the
effective interest rate method. The tables below summarise the
Group's main financial instruments by financial asset type:
|
|
31 March
2024
|
|
|
|
Amortised cost
|
Fair
value through profit or loss
|
Total
|
|
Group
|
Note
|
£'000
|
£'000
|
£'000
|
|
Financial assets
|
|
|
|
|
|
Other investments
|
6, 21
|
-
|
1,639
|
1,639
|
|
Trade and other
receivables
|
20
|
3,863
|
-
|
3,863
|
|
Cash and cash
equivalents
|
22
|
4,902
|
-
|
4,902
|
|
Financial liabilities
|
|
|
|
|
|
Trade and other
payables
|
23
|
2,929
|
-
|
2,929
|
|
Deferred consideration
|
24
|
875
|
-
|
875
|
|
Lease liability
|
18
|
293
|
-
|
293
|
|
|
|
|
31 March
2023
|
|
|
|
Amortised cost
|
Fair
value through profit or loss
|
Total
|
|
Group
|
Note
|
£'000
|
£'000
|
£'000
|
|
Financial assets
|
|
|
|
|
|
Other investments
|
17, 21
|
-
|
2,869
|
2,869
|
|
Trade and other
receivables
|
20
|
4,179
|
-
|
4,179
|
|
Cash and cash
equivalents
|
22
|
4,234
|
-
|
4,234
|
|
Financial liabilities
|
|
|
|
|
|
Trade and other
payables
|
23
|
3,418
|
-
|
3,418
|
|
Deferred consideration
|
24
|
2,121
|
-
|
2,121
|
|
Lease Liability
|
18
|
612
|
-
|
612
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The tables below summarise the Company's main
financial instruments by financial asset type:
|
|
31 March
2024
|
|
|
Amortised cost
|
Fair
value through profit or loss
|
Total
|
Company
|
Note
|
£'000
|
£'000
|
£'000
|
Financial assets
|
|
|
|
|
Trade and other
receivables
|
20
|
26
|
-
|
26
|
Amounts owed from Group
companies
|
|
4,676
|
-
|
4,676
|
Cash and cash
equivalents
|
22
|
-
|
-
|
-
|
Financial liabilities
|
|
|
|
|
Trade and other
payables
|
23
|
438
|
-
|
438
|
Amounts due to Group
companies
|
32
|
312
|
-
|
312
|
|
|
31 March
2023
|
|
|
Amortised cost
|
Fair
value through profit or loss
|
Total
|
Company
|
Note
|
£'000
|
£'000
|
£'000
|
Financial assets
|
|
|
|
|
Trade and other
receivables
|
20
|
14
|
-
|
14
|
Financial liabilities
|
|
|
|
|
Trade and other
payables
|
23
|
346
|
-
|
346
|
Amounts due to Group companies
|
32
|
790
|
-
|
790
|
Risks
The main risks arising from the Group's financial
instruments are credit risk, liquidity risk and market risk. Market
risk comprises, interest rate risk and other price risk. The
Directors review and agree policies for managing each of these
risks which are summarised below:
Credit risk
Credit risk is the risk that clients or other
counterparties to a financial instrument will cause a financial
loss by failing to meet their obligations. Credit risk relates, in
the main, to the Group's trading and investment activities and is
the risk that third parties fail to pay amounts as they fall due.
Formal credit procedures include approval of client limits,
approval of material trades, collateral in place for trading
clients and chasing of overdue accounts. Additionally, risk
assessments are performed on banks and custodians.
The maximum exposure to credit risk at the end of
the reporting period is equal to the statement of financial
position figure. The impairment policy can be found in note 20.
There were no other past due, impaired or unsecured debtors.
Financial assets that are neither past due nor
impaired in respect of trade receivables relate mainly to accrued
management fees.
The credit risk on liquid funds, cash and cash
equivalents is limited due to deposits being held at the Group's
main bank with a credit rating of "A", assigned by Standard and
Poor's.
There has been no change to the Group's exposure to
credit risk or the manner in which it manages and measures the risk
during the period.
The credit risk in the Company principally comes
from intercompany balances and subordinated loan. Since these are
all within the Group, the Directors can closely monitor the risk of
default on a regular basis to minimise any potential losses.
Liquidity risk
Liquidity risk is the risk that obligations
associated with financial liabilities will not be met. The Group
monitors its risk to a shortage of funds by considering the
maturity of both its financial investments and financial assets
(for example, trade receivables) and projected cash flows from
operations.
The Group's objective is to maintain the continuity
of funding using bank facilities where necessary, which are
reviewed annually with the Group's Banker, the Bank of Scotland.
Items considered are limits in place with counterparties which the
bank are required to guarantee, payment facility limits, as well as
the need for any additional borrowings.
The table below summarises the maturity profile of
the Group's financial liabilities based on contractual undiscounted
payments:
|
|
31 March
2024
|
|
|
Payable
within 1 year
|
Payable
in 2 to 5 years
|
Payable
after more than 5 years
|
Total
contractual payments
|
Group
|
Note
|
£'000
|
£'000
|
£'000
|
£'000
|
Trade and other
payables
|
23
|
2,929
|
-
|
-
|
2,929
|
Lease liability
|
6,18
|
110
|
210
|
-
|
320
|
Deferred consideration
|
24
|
875
|
-
|
-
|
875
|
|
|
3,914
|
210
|
-
|
4,124
|
|
|
31 March
2023
|
|
|
Payable
within 1 year
|
Payable
in 2 to 5 years
|
Payable
after more than 5 years
|
Total
contractual payments
|
Group
|
Note
|
£'000
|
£'000
|
£'000
|
£'000
|
Trade and other
payables
|
23
|
3,418
|
-
|
-
|
3,418
|
Lease liability
|
18
|
340
|
306
|
14
|
660
|
Deferred consideration
|
24
|
2,121
|
-
|
-
|
2,121
|
|
|
5,879
|
306
|
14
|
6,199
|
|
|
|
|
|
|
|
|
The table below summarises the maturity profile of
the Company's financial liabilities based on contractual
undiscounted payments:
|
31 March
2024
|
|
Payable
within 1 year
|
Payable
in 2 to 5 years
|
Payable
after more than 5 years
|
Total
contractual payments
|
Company
|
£'000
|
£'000
|
£'000
|
£'000
|
Trade and other
payables
|
438
|
-
|
-
|
438
|
|
31 March
2023
|
|
Payable
within 1 year
|
Payable
in 2 to 5 years
|
Payable
after more than 5 years
|
Total
contractual payments
|
Company
|
£'000
|
£'000
|
£'000
|
£'000
|
Trade and other
payables
|
346
|
-
|
-
|
346
|
Market Risk
Interest rate risk
The Group's exposure to the risk of changes in
market interest rates relates to the Group's amount of interest
receivable on cash deposits. The maximum exposure for interest is
not significant.
Other price risk
Other price risk is the risk that the fair value or
future cash flows of a financial instrument will fluctuate because
of changes in market prices (other than those arising from interest
rate risk) whether those changes are caused by factors specific to
the individual financial instrument or its issuer or factors
affecting all similar financial instruments traded in the market.
Other investments are recognised at fair value and subject to
changes in market prices.
The Group manages other price risk by monitoring the
value of its financial instruments monthly and reporting these to
the Directors and Senior Management. The Group has disposed of
several of its investments during the year, which has helped
mitigate risk. However, the risk of deterioration in prices remains
high whilst the market continues to be volatile.
The risk of future losses is limited to the fair
value of investments as at the year-end of £1,639k (FY23: £2,869k).
See note 17 and 21.
Fair value measurement recognised in the
statement of financial position
The following table provides an analysis of
financial instruments that are measured after initial recognition
at fair value, grouped into Levels 1 to 3 based on the degree to
which the fair value is observable:
· Level 1 at fair value
measurements are those derived from quoted prices (unadjusted) in
active markets for identical assets and liabilities;
· Level 2 fair value
measurements are those derived from inputs other than the quoted
price included within Level 1 that are observable for the asset or
a liability, either directly (i.e. as prices) or indirectly (i.e.
derived from prices); and
· Level 3 fair value
measurements are those derived from formal valuation techniques
that include inputs for the asset or liability that are not based
on observable market data (unobservable inputs). The valuation
technique used in determining the fair value is the Black Scholes
model. The key inputs into this calculation are the share price as
at 31 March 2024, exercise price, risk free interest rate and share
price volatility.
|
31 March
2024
|
|
Level
1
|
Level
2
|
Level
3
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Financial assets at fair value through profit or
loss
|
|
|
|
|
Unquoted equities
|
-
|
-
|
-
|
-
|
Financial instruments designated at fair value through profit
or loss
|
|
|
|
|
Other investments (note 17 &
21)
|
1,544
|
-
|
95
|
1,639
|
Total
|
1,544
|
-
|
95
|
1,639
|
|
31 March
2023
|
|
Level
1
|
Level
2
|
Level
3
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Financial assets at fair value through profit or
loss
|
|
|
|
|
Unquoted equities
|
-
|
-
|
-
|
-
|
Financial instruments designated at fair value through profit
or loss
|
|
|
|
|
Other investments (note 17 &
21)
|
2,049
|
-
|
820
|
2,869
|
Total
|
2,049
|
-
|
820
|
2,869
|
26. Capital
management
The capital of the Group comprises share capital,
share premium, retained earnings and other reserves. The total
capital at 31 March 2024 amounted to £14.3m for the Group (FY23:
£14.3m) and £23.7m for the Company (FY23: £24.3m). The primary
objective of the Group's capital management is to ensure that it
maintains a strong capital structure to support the development of
its business, to maximise shareholder value and to provide benefits
for its other stakeholders.
These objectives are met by managing the level of
debt and setting dividends paid to shareholders at a level
appropriate to the performance of the business.
Certain activities of the Group are regulated by the
FCA which is the statutory regulator for financial services
business and has responsibility for policy, monitoring and
discipline for the financial services industry. The FCA requires
the Group's resources to be adequate, that is, sufficient in terms
of quantity, quality and availability, in relation to its regulated
activities.
The Group monitors capital on a daily basis by
measuring movements in the Group regulatory capital requirement and
through its Internal Capital Adequacy and Risk Assessment Process
(ICARA), which was formerly through its Internal Capital Adequacy
Assessment Process (ICAAP). Compliance with FCA minimum common
equity tier 1 regulatory capital requirements was maintained during
the year and the Group is satisfied that there is and will be,
sufficient capital to meet these regulatory requirements for the
foreseeable future.
27. Share capital and share
premium account
|
Number of
shares
|
|
Share
|
Ordinary shares
|
Ordinary
shares
|
Deferred
shares
|
Share
capital
|
premium
|
|
000's
|
000's
|
£'000
|
£'000
|
As at 1 April 2022
|
62,086
|
-
|
3,104
|
19,014
|
Shares issued:
|
|
|
|
|
On placing
|
225
|
-
|
12
|
-
|
Balance at 31 March
2023
|
62,311
|
-
|
3,116
|
19,014
|
|
|
|
|
|
Shares issued:
|
|
|
|
|
To settle deferred
consideration
|
2,842
|
-
|
142
|
511
|
Share split
|
-
|
65,153
|
-
|
-
|
On placing
|
170,833
|
-
|
1,707
|
3,417
|
Share issue costs
|
-
|
-
|
-
|
(125)
|
Balance at 31 March 2024
|
235,986
|
65,153
|
4,965
|
22,817
|
The total number of ordinary shares in issue is
235.99 million of 1p each (31 March 2023: 62.31 million of 5p
each). The total number of deferred shares is 65.15 million (31
March 2023: nil) of 4p each.
During the year the group undertook a share placing,
which raised net proceeds of £5m by way of 170,833,333 ordinary
shares at a price of 3p. The placing took place on 28 July 2023 and
funds were received in August 2023. This decision was taken after
discussions with the FCA.
In order to permit the Placing Shares to be issued
at the Placing Price, which was lower than the nominal value of the
Existing Ordinary Shares, the Company divided each issued Existing
Ordinary Share (nominal value 5p each) into one New Ordinary Share
(nominal value 1p each) and one Deferred Share (nominal value 4p
each). The New Ordinary Shares have the same rights and benefits as
the Existing Ordinary Shares. Following the Share Sub-division, the
number of New Ordinary Shares held by each Shareholder were the
same as the number of Existing Ordinary Shares held by them
immediately before the Share Sub-division. The Deferred Shares were
not admitted to trading on AIM, have only very limited rights on a
return of capital and are effectively valueless and
non-transferable. As a result of the Share Sub-division, the
Company adopted the New Articles, which set out the rights and
restrictions applicable to the New Ordinary Shares and the New
Deferred Shares.
28. Treasury shares
|
Year ended 31 March
2024
|
Year
ended 31 March 2023
|
Group
|
£'000
|
£'000
|
At 31 March
|
1,093
|
900
|
Additions
|
21
|
193
|
At 31 March
|
1,114
|
1,093
|
At 31 March 2024 no shares in the Company were held
in the EBT (FY23: nil shares) and the ESOT held 3,117,418 shares
(FY23: 3,017,418), at a nominal value of 1p per share and
represents the full balance above. This represents 1.32% of the
called up share capital (FY23: 4.84%). The company loaned the
amount required for the ESOT to purchase the shares as
required.
During the year the Company's Employee Share Option
trust (ESOT) purchased the following ordinary shares in the
Company:
|
Number of
shares
|
Nominal
value
|
Total
consideration
|
Date of
issue
|
000's
|
£'000
|
£'000
|
20-Apr-23
|
50,000
|
5p
|
9,500
|
12-Jun-23
|
10,000
|
5p
|
2,310
|
20-Jun-23
|
40,000
|
5p
|
9,240
|
29. Employee Benefit Trusts
(EBT)
The WH Ireland EBT was established in October 1998
and the WH Ireland Group plc Employee Share Ownership Trust (ESOT)
was established in October 2011, both for the purpose of holding
and distributing shares in the Company for the benefit of the
employees. All costs of the EBT and ESOT are borne by the Company
or its subsidiary WH Ireland Limited.
Joint Ownership Arrangements (the 'JOE Agreements')
are in place in relation to 400,000 shares between the trustees of
the ESOT and a number of employees (the 'Employees'). Under the JOE
Agreements, the option for the Employees to acquire the interest
that the trustees of the ESOT has in the jointly owned shares,
lapses when an employee is deemed to be a Bad Leaver. If an
Employee ceases to be an employee of the Group, other than in the
event of critical illness or death, the Employee is deemed to be a
Bad Leaver.
The shares carry dividend and voting rights though
these have been waived by all parties to the JOE Agreements. Due to
the consolidation of the ESOT into the Group accounts, these shares
are shown in Treasury (note 28). Due to the nature of these
arrangements, the options contained in the JOE Agreements are
accounted for as share-based payments (note 30).
30. Share-based payments
The Group had two schemes for the granting of
non-transferable options to employees during the reporting period;
the approved Company Share Ownership Plan (CSOP) and a Save as You
Earn Schemes (SAYE). In addition, options are held in the ESOT
(note 29). SAYE matures in July 2025.
Company Share Ownership Plan (CSOP)
Under the terms of the Unapproved Options, options
over the Company's shares may be granted on a discretionary basis
to employees and consultants of the Group (including Directors) at
a price to be agreed between the Company and the relevant option
holder. Under the terms of the options granted, such options vest
on the third anniversary of the award dates; are exercisable at the
market price at the time the option was issued and are exercisable
for ten years after the vesting date.
Salary Sacrifice Scheme
During the year, directors agreed to sacrifice a
proportion of their respective salaries in consideration of being
awarded with options to subscribe, at nil cost, for a number of New
Ordinary Shares, with such options vesting on a monthly basis over
such period and (subject to vesting) which may be exercised in the
period of ten years following the date of vesting. Vesting is
subject to their remaining an employee of the Company at the
relevant time.
Movements in the number of share options outstanding
that were issued post 7 November 2002 and their related weighted
average exercise prices (WAEP) are as follows:
|
31 March
2024
|
|
ESOT
|
ESOT
|
2019
LTIP
|
2020 EMI
Option Plan
|
2022 EMI
Option Plan
|
Salary
Sacrifice Plan
|
|
Options
|
WAEP
|
Options
|
WAEP
|
Options
|
WAEP
|
Options
|
WAEP
|
Options
|
WAEP
|
Options
|
WAEP
|
|
Outstanding at beginning of
year
|
250,000
|
74.50p
|
50,000
|
92.5p
|
1,650,000
|
45.00p
|
2,936,361
|
44.45p
|
2,678,568
|
46.00p
|
-
|
-
|
|
Granted
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
13,066,665
|
-
|
|
Expired / forfeited
|
(250,000)
|
74.50p
|
-
|
-
|
(150,000)
|
45.00p
|
(208,333)
|
48.00p
|
(1,428,570)
|
46.00p
|
-
|
-
|
|
Exercised
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Outstanding at end of year
|
-
|
-
|
50,000
|
92.50p
|
1,500,000
|
45.00p
|
2,728,028
|
30.82p
|
1,249,998
|
46.00p
|
13,066,665
|
-
|
|
Exercisable at end of year
|
-
|
-
|
50,000
|
92.50p
|
1,500,000
|
45.00p
|
2,728,028
|
30.82p
|
1,249,998
|
46.00p
|
3,266,666
|
-
|
|
WA Life*
|
-
|
2.01
yrs
|
6.10
yrs
|
9.68
yrs
|
8.32
yrs
|
10.27
yrs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* WA Life represents the weighted average
contractual life in years to the expiry date for options
outstanding at the end of the year.
|
|
31 March
2023
|
|
CSOP
|
ESOT
|
ESOT
|
2019
LTIP
|
2020 EMI
Option Plan
|
2022 EMI
Option Plan
|
|
Options
|
WAEP
|
Options
|
WAEP
|
Options
|
WAEP
|
Options
|
WAEP
|
Options
|
WAEP
|
Options
|
WAEP
|
Outstanding at beginning of
year
|
35,502
|
84.50p
|
350,000
|
74.50p
|
50,000
|
92.5p
|
1,800,000
|
45.00p
|
3,644,170
|
37.34p
|
-
|
-
|
Granted
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2,678,568
|
46.00p
|
Expired / forfeited
|
(35,502)
|
84.50p
|
(100,000)
|
74.50p
|
-
|
-
|
(150,000)
|
45.00p
|
(260,416)
|
48.00p
|
|
-
|
Exercised
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(447,393)
|
48.00p
|
-
|
-
|
Outstanding at end of year
|
-
|
0.00p
|
250,000
|
74.50p
|
50,000
|
92.50p
|
1,650,000
|
45.00p
|
2,936,361
|
44.45p
|
2,678,568
|
46.00p
|
Exercisable at end of year
|
-
|
0.00p
|
250,000
|
74.50p
|
50,000
|
92.50p
|
1,650,000
|
45.00p
|
2,936,361
|
44.45p
|
2,678,568
|
46.00p
|
WA
Life*
|
-
|
0.50
yrs
|
3.01
yrs
|
7.10
yrs
|
10.68
yrs
|
9.32
yrs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* WA Life represents the weighted average
contractual life in years to the expiry date for options
outstanding at the end of the year.
|
|
Pricing
Models
|
|
ESOT
|
ESOT
|
2019
LTIP
|
2020 EMI
Option Plan
|
2022 EMI
Option Plan
|
Salary
Sacrifice Plan
|
Pricing model
|
Monte
Carlo
|
N/A
|
Black Scholes
|
Black Scholes
|
Black Scholes
|
N/A
|
Date of grant
|
28/10/13-13/4/16
|
30/05/17
|
28/06/19
& 28/12/19
|
01/11/20
- 01/09/21
|
01/04/22
- 01/11/22
|
28/09/23
|
Share price at grant (p)
|
74.5-114.5
|
125
|
45.0
& 49.0
|
42.0-56.5
|
30.0-45.00
|
5.5
|
Exercise price (p)
|
0.0-114.5
|
-
|
45.0
& 49.0
|
0.0-58.0
|
42.0-48.0
|
-
|
Expected volatility (%)
|
43.0000-37.0000
|
N/A
|
50
|
50
|
21-22
|
N/A
|
Expected life (years)
|
5
|
3
|
3
|
1-3
|
3
|
2
|
Risk-free rate (%)
|
0.8000-1.9300
|
N/A
|
2
|
5
|
1.38-3.22
|
N/A
|
Expected dividend yield (%)
|
0.67-2.19
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
The pricing models used to value these options and
their inputs are as follows:
31. Capital
commitments
There were no capital commitments for the Group or
the Company as at 31 March 2024 (FY23: £nil).
32. Related party transactions
Group
Services rendered to related parties were on the
Group's normal trading terms in an arms' length transaction.
Amounts outstanding are unsecured and will be settled in accordance
with normal credit terms. No guarantees have been given or
received. No provision (FY23: £nil) has been made for impaired
receivables in respect of the amounts owed by related parties.
Key management personnel include Executive and
Non-Executive Directors of WH Ireland Group plc and all its
subsidiaries. They can undertake transactions in stocks and shares
in the ordinary course of the Group's business, for their own
account and are charged for this service, as with any other client.
The transactions are not material to the Group in the context of
its operations, but may result in cash balances on the Directors'
client accounts owing to or from the Group at any one point in
time. The charges made to these individuals and the cash balances
owing from/due to them are disclosed in the table below. There are
no other material contracts between the Group and the
Directors.
No transactions occurred with key management
personnel and other relates parties during the year ended 31 March
2024 or 31 March 2023.
The total compensation of key management personnel
is shown below:
|
Year ended 31 March
2024
|
Year ended 31 March
2023
|
|
£'000
|
£'000
|
Short-term employee
benefits
|
2,565
|
2,528
|
|
2,565
|
2,528
|
The highest paid Director for 2024 was P Wale
receiving emoluments of £374,216 (FY23: £470,868).
Company
The Parent Company receives interest from
subsidiaries in the normal course of business. Total interest
received during the year was £nil (FY23: £nil). In addition, the
Parent Company received a management charge of £999k (FY23: £879k)
from its subsidiary WH Ireland Limited. WH Ireland Limited also
charged the Parent Company £nil (FY23: £nil) for broker
services.
Transactions between the Company and its
subsidiaries, which are related parties, have been eliminated on
consolidation. The captions in the primary statements of the Parent
Company include amounts attributable to subsidiaries. These amounts
have been disclosed in aggregate in the notes 16, 20 and 23 and in
detail in the following table:
|
Amounts
owed by related parties
|
Amounts
owed to related parties
|
|
2024
|
2023
|
2024
|
2023
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Readycount Limited
|
-
|
-
|
-
|
-
|
Stockholm Investments
Limited
|
-
|
-
|
-
|
-
|
WH Ireland Limited
|
4,676
|
-
|
-
|
478
|
Harpsden WM Limited
|
-
|
-
|
295
|
295
|
WH Ireland Trustee
Limited
|
-
|
-
|
17
|
17
|
|
4,676
|
-
|
312
|
790
|
The net amount owed by related parties is £4,364k
(FY23: £790k owed to related parties) (see note 20 and 23).
The placing that took place during the year resulted
in an amount owed by WH Ireland Limited to the Parent Company of
£4.7m. This is due to the shares included in the placing were in
the Parent Company, and the cash received by WH Ireland Limited to
be used in the operation of the business.
33. Events after the reporting date
Successful sale of the CM business
Post year end, the Group completed
on the sale of the CM division on the 12th July 2024.
This sale has resulted in a positive regulatory capital position
and changed requirements. The sale will also increase potential
cash inflows if and when the deferred consideration (of up to £5
million) is paid, shortly following the first anniversary of
completion of the Transaction.
The deferred consideration is to
be paid in cash within 30 days of the first anniversary of
Completion and is to be calculated by reference to the retainer and
transaction revenue generated by the CM Division within the 12
months after Completion. This amount is to be the aggregate of 20%
of the Retainer Fees, 30% of the Transaction Fees, 75% of the
Market Making Equity Value and, subject to the Relevant Retainer
Fees being equal to or greater than £2.75m, an amount equal to the
Market Making Cash (£250k).
Decision by the Board to no longer actively pursue a sale of
the WM business
After the year-end the sale of the WM division did not
proceed. However, at the year end date and shortly after the Board
remained committed to the disposal and therefore the WM division is
classified as a discontinued operation and the assets and
liabilities form part of the disposal group at 31 March 2024. This,
along with the successful sale of the CM division as announced on 3
June 2024, prompted management to reassess the strategy for the WM
division. From this date, the WM division was removed from the
disposal group. The Group will now focus on implementing
improvements to the remaining WM division as well as making changes
that will increase efficiencies across the business. Consequently,
this division will no longer be held for sale or be shown as a
discontinued operation in the 2025 financial year. Results for the
WM division have been isolated and presented in note 5.